Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	L-leucine binding	SESN3 GLUD1 GLUD2	2.66e-05	7	185	3	GO:0070728
GeneOntologyMolecularFunction	oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor	GLUD1 GLUD2	8.54e-05	2	185	2	GO:0016639
GeneOntologyMolecularFunction	TFIIIC-class transcription factor complex binding	BDP1 MTOR	8.54e-05	2	185	2	GO:0001156
GeneOntologyMolecularFunction	glutamate dehydrogenase [NAD(P)+] activity	GLUD1 GLUD2	8.54e-05	2	185	2	GO:0004353
GeneOntologyMolecularFunction	glutamate dehydrogenase (NAD+) activity	GLUD1 GLUD2	8.54e-05	2	185	2	GO:0004352
GeneOntologyMolecularFunction	glutamate dehydrogenase (NADP+) activity	GLUD1 GLUD2	8.54e-05	2	185	2	GO:0004354
GeneOntologyMolecularFunction	dynein intermediate chain binding	DNAAF5 DNAH12 DNAH17 DNAH9	3.71e-04	37	185	4	GO:0045505
GeneOntologyMolecularFunction	RNA polymerase III general transcription initiation factor binding	BDP1 MTOR	5.06e-04	4	185	2	GO:0001025
GeneOntologyMolecularFunction	synaptic receptor adaptor activity	SHANK3 SHANK2	5.06e-04	4	185	2	GO:0030160
GeneOntologyMolecularFunction	minus-end-directed microtubule motor activity	DNAH12 DNAH17 DNAH9	5.76e-04	18	185	3	GO:0008569
GeneOntologyMolecularFunction	amino acid binding	FMO3 SESN3 GLUD1 GLUD2 GOT2	5.83e-04	73	185	5	GO:0016597
GeneOntologyBiologicalProcess	regulation of cell projection organization	ACSL6 FLNA ARHGAP32 CDC42EP4 DOCK11 MAPT ICAM1 DVL2 SMURF1 IFT46 INPP5F CUL7 SHANK3 ACTR2 RUFY3 KIAA0319 IFRD1 TIAM1 NFATC4 MTOR AVIL CSPG4 ANAPC2 MACF1 QKI	1.93e-07	863	183	25	GO:0031344
GeneOntologyBiologicalProcess	regulation of plasma membrane bounded cell projection organization	ACSL6 FLNA ARHGAP32 CDC42EP4 DOCK11 MAPT ICAM1 SMURF1 IFT46 INPP5F CUL7 SHANK3 ACTR2 RUFY3 KIAA0319 IFRD1 TIAM1 NFATC4 MTOR AVIL CSPG4 ANAPC2 MACF1 QKI	5.06e-07	846	183	24	GO:0120035
GeneOntologyBiologicalProcess	regulation of neuron projection development	ACSL6 FLNA ARHGAP32 MAPT SMURF1 INPP5F CUL7 SHANK3 ACTR2 RUFY3 KIAA0319 IFRD1 TIAM1 NFATC4 MTOR AVIL CSPG4 ANAPC2 MACF1 QKI	5.62e-07	612	183	20	GO:0010975
GeneOntologyBiologicalProcess	positive regulation of cell projection organization	ACSL6 FLNA ARHGAP32 CDC42EP4 DOCK11 MAPT DVL2 SMURF1 CUL7 ACTR2 RUFY3 TIAM1 MTOR AVIL ANAPC2 MACF1 QKI	2.08e-06	494	183	17	GO:0031346
GeneOntologyBiologicalProcess	axon extension	ARHGAP32 MAPT USP9X SMURF1 RUFY3 KIAA0319 IFRD1 ANAPC2 MACF1	3.35e-06	135	183	9	GO:0048675
GeneOntologyBiologicalProcess	positive regulation of neurogenesis	ARHGAP32 MAPT SMURF1 CUL7 XRCC2 SHANK3 ACTR2 RUFY3 TIAM1 MTOR ANAPC2 MACF1 QKI SPEN	3.55e-06	354	183	14	GO:0050769
GeneOntologyBiologicalProcess	regulation of neurogenesis	ARHGAP32 MAPT SMURF1 CUL7 XRCC2 SHANK3 ACTR2 RUFY3 KIAA0319 IFRD1 TIAM1 NFATC4 MTOR ANAPC2 MACF1 QKI SPEN	3.64e-06	515	183	17	GO:0050767
GeneOntologyBiologicalProcess	regulation of axon extension	ARHGAP32 MAPT SMURF1 RUFY3 KIAA0319 IFRD1 ANAPC2 MACF1	4.11e-06	104	183	8	GO:0030516
GeneOntologyBiologicalProcess	positive regulation of nervous system development	ARHGAP32 MAPT SMURF1 CLSTN2 CUL7 XRCC2 SHANK3 ACTR2 RUFY3 TIAM1 MTOR ANAPC2 MACF1 QKI SPEN	5.15e-06	418	183	15	GO:0051962
GeneOntologyBiologicalProcess	regulation of cell size	ARHGAP32 MAPT SMURF1 SHANK3 RUFY3 KIAA0319 IFRD1 MTOR ANAPC2 MACF1 WNK3	5.61e-06	225	183	11	GO:0008361
GeneOntologyBiologicalProcess	regulation of cellular component size	ARHGAP32 CDC42EP4 MAPT SPTA1 ICAM1 SMURF1 SHANK3 RUFY3 KIAA0319 IFRD1 MTOR AVIL ANAPC2 MACF1 WNK3	6.47e-06	426	183	15	GO:0032535
GeneOntologyBiologicalProcess	plasma membrane bounded cell projection assembly	FLNA ERICH3 CDC42EP4 DOCK11 USP9X ICAM1 BBIP1 CILK1 IFT46 ACTR2 CEP164 WDR19 DNAAF5 MTOR AVIL CSPG4 DNAH17 CC2D2A HYDIN	8.56e-06	670	183	19	GO:0120031
GeneOntologyBiologicalProcess	positive regulation of axon extension	ARHGAP32 MAPT SMURF1 RUFY3 ANAPC2 MACF1	9.08e-06	55	183	6	GO:0045773
GeneOntologyBiologicalProcess	neuron projection development	ACSL6 HSPG2 FLNA ARHGAP32 MAPT USP9X CECR2 DVL2 SMURF1 NR4A3 ADGRV1 INPP5F CUL7 SHANK3 ACTR2 RUFY3 KIAA0319 IFRD1 DST TIAM1 NFATC4 MTOR CLMN AVIL CSPG4 ANAPC2 MACF1 QKI	9.36e-06	1285	183	28	GO:0031175
GeneOntologyBiologicalProcess	cell projection assembly	FLNA ERICH3 CDC42EP4 DOCK11 USP9X ICAM1 BBIP1 CILK1 IFT46 ACTR2 CEP164 WDR19 DNAAF5 MTOR AVIL CSPG4 DNAH17 CC2D2A HYDIN	1.17e-05	685	183	19	GO:0030031
GeneOntologyBiologicalProcess	regulation of nervous system development	ARHGAP32 MAPT SMURF1 CLSTN2 CUL7 XRCC2 SHANK3 ACTR2 RUFY3 KIAA0319 IFRD1 TIAM1 NFATC4 MTOR ANAPC2 MACF1 QKI SPEN	1.22e-05	625	183	18	GO:0051960
GeneOntologyBiologicalProcess	regulation of extent of cell growth	ARHGAP32 MAPT SMURF1 RUFY3 KIAA0319 IFRD1 ANAPC2 MACF1	1.34e-05	122	183	8	GO:0061387
GeneOntologyBiologicalProcess	developmental cell growth	ARHGAP32 MAPT USP9X SMURF1 RUFY3 KIAA0319 IFRD1 TIAM1 MTOR ANAPC2 MACF1 AKAP13	1.66e-05	301	183	12	GO:0048588
GeneOntologyBiologicalProcess	neuron projection extension	ARHGAP32 MAPT USP9X SMURF1 RUFY3 KIAA0319 IFRD1 TIAM1 ANAPC2 MACF1	1.67e-05	207	183	10	GO:1990138
GeneOntologyBiologicalProcess	cell morphogenesis	HSPG2 FLNA ARHGAP32 CDC42EP4 ZMPSTE24 MAPT USP9X COL27A1 SPTA1 CNMD ICAM1 DVL2 SMURF1 NR4A3 CUL7 SHANK3 ACTR2 RUFY3 KIAA0319 WDR19 IFRD1 DST TIAM1 NFATC4 ANAPC2 MACF1	2.05e-05	1194	183	26	GO:0000902
GeneOntologyBiologicalProcess	glutamate catabolic process	GLUD1 GLUD2 GOT2	3.72e-05	8	183	3	GO:0006538
GeneOntologyBiologicalProcess	regulation of anatomical structure size	ARHGAP32 HNF1B CDC42EP4 HTR2C MAPT SPTA1 ICAM1 SMURF1 SHANK3 RUFY3 KIAA0319 IFRD1 MTOR AVIL ANAPC2 MACF1 WNK3	3.82e-05	618	183	17	GO:0090066
GeneOntologyBiologicalProcess	ribonucleoside diphosphate metabolic process	RRM2 FBP1 NUDT5 MTOR ENTPD5 PKLR FOXK1 TPI1	4.22e-05	143	183	8	GO:0009185
GeneOntologyBiologicalProcess	cilium assembly	FLNA ERICH3 USP9X BBIP1 CILK1 IFT46 ACTR2 CEP164 WDR19 DNAAF5 AVIL DNAH17 CC2D2A HYDIN	4.46e-05	444	183	14	GO:0060271
GeneOntologyBiologicalProcess	negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay	A1CF NBAS SYNCRIP	5.55e-05	9	183	3	GO:2000623
GeneOntologyBiologicalProcess	regulation of axonogenesis	ARHGAP32 MAPT SMURF1 RUFY3 KIAA0319 IFRD1 TIAM1 ANAPC2 MACF1	5.62e-05	192	183	9	GO:0050770
GeneOntologyBiologicalProcess	nucleoside diphosphate metabolic process	RRM2 FBP1 NUDT5 MTOR ENTPD5 PKLR FOXK1 TPI1	5.66e-05	149	183	8	GO:0009132
GeneOntologyBiologicalProcess	positive regulation of axonogenesis	ARHGAP32 MAPT SMURF1 RUFY3 TIAM1 ANAPC2 MACF1	7.14e-05	114	183	7	GO:0050772
GeneOntologyBiologicalProcess	developmental growth involved in morphogenesis	ARHGAP32 HNF1B MAPT USP9X SMURF1 RUFY3 KIAA0319 IFRD1 TIAM1 ANAPC2 MACF1	7.74e-05	299	183	11	GO:0060560
GeneOntologyBiologicalProcess	regulation of cell morphogenesis	CDC42EP4 ZMPSTE24 SPTA1 ICAM1 DVL2 SMURF1 CUL7 ACTR2 TIAM1 ANAPC2 MACF1	8.46e-05	302	183	11	GO:0022604
GeneOntologyBiologicalProcess	cilium organization	FLNA ERICH3 USP9X BBIP1 CILK1 IFT46 ACTR2 CEP164 WDR19 DNAAF5 AVIL DNAH17 CC2D2A HYDIN	9.38e-05	476	183	14	GO:0044782
GeneOntologyBiologicalProcess	neuron development	ACSL6 HSPG2 FLNA ARHGAP32 MAPT USP9X CECR2 DVL2 SMURF1 NR4A3 ADGRV1 INPP5F CUL7 SHANK3 ACTR2 RUFY3 KIAA0319 IFRD1 DST TIAM1 NFATC4 MTOR CLMN AVIL CSPG4 ANAPC2 MACF1 QKI	9.43e-05	1463	183	28	GO:0048666
GeneOntologyBiologicalProcess	regulation of double-strand break repair via homologous recombination	RUVBL2 ACTR2 DMAP1 RIF1 PPP4C PARPBP	9.63e-05	83	183	6	GO:0010569
GeneOntologyBiologicalProcess	regulation of anatomical structure morphogenesis	HSPG2 ARHGAP32 FLT4 CDC42EP4 ZMPSTE24 MAPT SPTA1 CNMD ICAM1 DVL2 SMURF1 CUL7 SHANK3 ACTR2 RUFY3 KIAA0319 IFRD1 TIAM1 NFATC4 TJP1 ANAPC2 MACF1 QKI	1.03e-04	1090	183	23	GO:0022603
GeneOntologyBiologicalProcess	ribonucleoside diphosphate catabolic process	FBP1 NUDT5 MTOR ENTPD5 PKLR FOXK1 TPI1	1.04e-04	121	183	7	GO:0009191
GeneOntologyBiologicalProcess	nucleoside diphosphate catabolic process	FBP1 NUDT5 MTOR ENTPD5 PKLR FOXK1 TPI1	1.21e-04	124	183	7	GO:0009134
GeneOntologyBiologicalProcess	DNA damage response	TTF2 EGLN3 EXO5 ZMPSTE24 MAPT USP9X TRAIP XRCC2 RUVBL2 ACTR2 CEP164 DMAP1 RIF1 PPP4C NFATC2 NFATC4 MTOR PRAP1 TOPORS PARPBP PTTG2	1.26e-04	959	183	21	GO:0006974
GeneOntologyBiologicalProcess	cell growth	ARHGAP32 FLT4 MAPT USP9X SMURF1 RUFY3 KIAA0319 IFRD1 FBP1 TIAM1 MTOR ANAPC2 MACF1 AKAP13 FOXK1 PTTG2	1.49e-04	625	183	16	GO:0016049
GeneOntologyBiologicalProcess	organelle assembly	FLNA ERICH3 MAPT USP9X SMURF1 BBIP1 CILK1 ATG14 IFT46 SHANK3 ACTR2 CEP164 WDR19 DNAAF5 MTOR AVIL DNAH17 HPS6 CC2D2A AKAP13 KIF2A HYDIN WNK3	1.94e-04	1138	183	23	GO:0070925
GeneOntologyBiologicalProcess	regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay	A1CF NBAS SYNCRIP	2.33e-04	14	183	3	GO:2000622
GeneOntologyBiologicalProcess	neuron projection morphogenesis	HSPG2 ARHGAP32 MAPT USP9X DVL2 SMURF1 NR4A3 CUL7 SHANK3 ACTR2 RUFY3 KIAA0319 IFRD1 DST TIAM1 NFATC4 ANAPC2 MACF1	2.92e-04	802	183	18	GO:0048812
GeneOntologyBiologicalProcess	dicarboxylic acid biosynthetic process	GLUD1 GLUD2 GOT2	3.53e-04	16	183	3	GO:0043650
GeneOntologyBiologicalProcess	cell morphogenesis involved in neuron differentiation	HSPG2 ARHGAP32 MAPT USP9X SMURF1 NR4A3 CUL7 SHANK3 ACTR2 RUFY3 KIAA0319 IFRD1 DST TIAM1 NFATC4 ANAPC2 MACF1	3.75e-04	748	183	17	GO:0048667
GeneOntologyBiologicalProcess	plasma membrane bounded cell projection morphogenesis	HSPG2 ARHGAP32 MAPT USP9X DVL2 SMURF1 NR4A3 CUL7 SHANK3 ACTR2 RUFY3 KIAA0319 IFRD1 DST TIAM1 NFATC4 ANAPC2 MACF1	3.75e-04	819	183	18	GO:0120039
GeneOntologyBiologicalProcess	cell projection morphogenesis	HSPG2 ARHGAP32 MAPT USP9X DVL2 SMURF1 NR4A3 CUL7 SHANK3 ACTR2 RUFY3 KIAA0319 IFRD1 DST TIAM1 NFATC4 ANAPC2 MACF1	4.15e-04	826	183	18	GO:0048858
GeneOntologyBiologicalProcess	TORC2 signaling	USP9X SESN3 MTOR	4.26e-04	17	183	3	GO:0038203
GeneOntologyBiologicalProcess	positive regulation of cellular component organization	ACSL6 FLNA ARHGAP32 CDC42EP4 DOCK11 MAPT ICAM1 DVL2 CKAP5 SMURF1 CLSTN2 CUL7 RUVBL2 SHANK3 ACTR2 RUFY3 TIAM1 NFATC2 MTOR AHNAK AVIL ANAPC2 PRAP1 MACF1 QKI	4.53e-04	1366	183	25	GO:0051130
GeneOntologyBiologicalProcess	mRNA localization resulting in post-transcriptional regulation of gene expression	A1CF CKAP5	4.64e-04	4	183	2	GO:0010609
GeneOntologyBiologicalProcess	intracellular mRNA localization	A1CF CKAP5 QKI	5.08e-04	18	183	3	GO:0008298
GeneOntologyBiologicalProcess	regulation of supramolecular fiber organization	HSPG2 FLNA CDC42EP4 MAPT SPTA1 ICAM1 CKAP5 SHANK3 TJP1 MTOR AVIL AKAP13	5.62e-04	438	183	12	GO:1902903
GeneOntologyBiologicalProcess	negative regulation of mRNA metabolic process	A1CF U2AF2 NBAS MTOR QKI SYNCRIP	5.68e-04	115	183	6	GO:1903312
GeneOntologyBiologicalProcess	axon development	HSPG2 FLNA ARHGAP32 MAPT USP9X SMURF1 NR4A3 INPP5F RUFY3 KIAA0319 IFRD1 DST TIAM1 ANAPC2 MACF1	6.27e-04	642	183	15	GO:0061564
GeneOntologyBiologicalProcess	positive regulation of cell growth	ARHGAP32 FLT4 MAPT SMURF1 RUFY3 MTOR ANAPC2 MACF1	6.47e-04	213	183	8	GO:0030307
GeneOntologyBiologicalProcess	amyloid fibril formation	HSPG2 MAPT USP9X NUP153	6.72e-04	45	183	4	GO:1990000
GeneOntologyBiologicalProcess	dicarboxylic acid catabolic process	GLUD1 GLUD2 GOT2	7.01e-04	20	183	3	GO:0043649
GeneOntologyBiologicalProcess	regulation of cell growth	ARHGAP32 FLT4 MAPT SMURF1 RUFY3 KIAA0319 IFRD1 FBP1 MTOR ANAPC2 MACF1 FOXK1 PTTG2	7.68e-04	519	183	13	GO:0001558
GeneOntologyBiologicalProcess	glutamate biosynthetic process	GLUD1 GLUD2	7.69e-04	5	183	2	GO:0006537
GeneOntologyCellularComponent	cilium	ERICH3 PDE6B MAPT USP9X ABHD2 BBIP1 CILK1 ATG14 IFT46 ADGRV1 SHANK3 CEP164 WDR19 DNAAF5 DNAH12 SHANK2 TIAM1 GUCY2F TTLL2 GLIS2 DNAH17 CC2D2A KIF2A TOPORS DNAH9 HYDIN PTTG2	2.36e-08	898	184	27	GO:0005929
GeneOntologyCellularComponent	non-motile cilium	ERICH3 PDE6B ADGRV1 WDR19 SHANK2 TIAM1 GUCY2F GLIS2 TOPORS	6.21e-05	196	184	9	GO:0097730
Domain	ARM-type_fold	DOCK11 USP9X CKAP5 CUL7 RYR3 ARFGEF3 DNAAF5 RIF1 IFRD1 PPP2R5E MTOR AOPEP LTN1 MROH7 AP1G2	1.51e-06	339	185	15	IPR016024
Domain	ConA-like_dom	HSPG2 COL20A1 COL27A1 TRIM43 CLSTN2 ADGRV1 RYR3 TRIM43B FAT2 CSPG4 SEL1L3 TRIM16L	1.97e-06	219	185	12	IPR013320
Domain	NFAT	NFATC1 NFATC2 NFATC4	9.42e-06	5	185	3	IPR008366
Domain	ACTININ_2	FLNA DST CLMN MACF1	7.12e-05	23	185	4	PS00020
Domain	ACTININ_1	FLNA DST CLMN MACF1	7.12e-05	23	185	4	PS00019
Domain	Actinin_actin-bd_CS	FLNA DST CLMN MACF1	7.12e-05	23	185	4	IPR001589
Domain	-	USP9X CKAP5 CUL7 DNAAF5 RIF1 IFRD1 PPP2R5E MTOR MROH7 AP1G2	7.61e-05	222	185	10	1.25.10.10
Domain	PDZ	DVL2 SHANK3 SHANK2 TIAM1 TJP1 AHNAK FRMPD3 AHNAK2	8.22e-05	141	185	8	PF00595
Domain	ARM-like	USP9X CKAP5 CUL7 DNAAF5 RIF1 IFRD1 PPP2R5E MTOR LTN1 MROH7 AP1G2	8.23e-05	270	185	11	IPR011989
Domain	ELFV_dehydrog_N	GLUD1 GLUD2	9.76e-05	2	185	2	PF02812
Domain	Glu/Leu/Phe/Val_DH_C	GLUD1 GLUD2	9.76e-05	2	185	2	IPR006096
Domain	Glu/Leu/Phe/Val_DH_dimer_dom	GLUD1 GLUD2	9.76e-05	2	185	2	IPR006097
Domain	Glu/Leu/Phe/Val_DH	GLUD1 GLUD2	9.76e-05	2	185	2	IPR006095
Domain	ELFV_dehydrog	GLUD1 GLUD2	9.76e-05	2	185	2	PF00208
Domain	NAD_bind_Glu_DH	GLUD1 GLUD2	9.76e-05	2	185	2	IPR033922
Domain	GLFV_DEHYDROGENASE	GLUD1 GLUD2	9.76e-05	2	185	2	PS00074
Domain	ELFV_dehydrog	GLUD1 GLUD2	9.76e-05	2	185	2	SM00839
Domain	Glu/Leu/Phe/Val_DH_AS	GLUD1 GLUD2	9.76e-05	2	185	2	IPR033524
Domain	RHD_dimer	NFATC1 NFATC2 NFATC4	1.09e-04	10	185	3	IPR032397
Domain	RHD_dimer	NFATC1 NFATC2 NFATC4	1.09e-04	10	185	3	PF16179
Domain	REL_1	NFATC1 NFATC2 NFATC4	1.09e-04	10	185	3	PS01204
Domain	-	NFATC1 NFATC2 NFATC4	1.09e-04	10	185	3	2.60.40.340
Domain	NFkB/Dor	NFATC1 NFATC2 NFATC4	1.09e-04	10	185	3	IPR000451
Domain	RHD_DNA_bind_dom	NFATC1 NFATC2 NFATC4	1.09e-04	10	185	3	IPR011539
Domain	RHD_DNA_bind	NFATC1 NFATC2 NFATC4	1.09e-04	10	185	3	PF00554
Domain	REL_2	NFATC1 NFATC2 NFATC4	1.09e-04	10	185	3	PS50254
Domain	PDZ	DVL2 SHANK3 SHANK2 TIAM1 TJP1 AHNAK FRMPD3 AHNAK2	1.15e-04	148	185	8	SM00228
Domain	-	DVL2 SHANK3 SHANK2 TIAM1 TJP1 AHNAK FRMPD3 AHNAK2	1.27e-04	150	185	8	2.30.42.10
Domain	PDZ	DVL2 SHANK3 SHANK2 TIAM1 TJP1 AHNAK FRMPD3 AHNAK2	1.32e-04	151	185	8	PS50106
Domain	PDZ	DVL2 SHANK3 SHANK2 TIAM1 TJP1 AHNAK FRMPD3 AHNAK2	1.39e-04	152	185	8	IPR001478
Domain	Laminin_G	HSPG2 COL20A1 COL27A1 FAT2 CSPG4	2.71e-04	58	185	5	IPR001791
Domain	LAM_G_DOMAIN	HSPG2 COL27A1 FAT2 CSPG4	5.29e-04	38	185	4	PS50025
Domain	HnRNP_R/Q_splicing_fac	A1CF SYNCRIP	9.57e-04	5	185	2	IPR006535
Domain	Cadherin	PCDHGA3 CLSTN2 KIAA0319 FAT2 PCDHB1 PCDHGC3	1.15e-03	118	185	6	IPR002126
Domain	-	DST MACF1	1.43e-03	6	185	2	3.90.1290.10
Domain	GAR	DST MACF1	1.43e-03	6	185	2	PS51460
Domain	GAS2	DST MACF1	1.43e-03	6	185	2	PF02187
Domain	-	DST MACF1	1.43e-03	6	185	2	3.30.920.20
Domain	GAS_dom	DST MACF1	1.43e-03	6	185	2	IPR003108
Domain	GAS2	DST MACF1	1.43e-03	6	185	2	SM00243
Domain	SH3	ARHGAP32 SPTA1 SHANK3 DST SHANK2 TJP1 MACF1 ARHGEF37	1.43e-03	216	185	8	PS50002
Domain	Spectrin	SPTA1 DST MACF1	1.46e-03	23	185	3	PF00435
Domain	SH3_domain	ARHGAP32 SPTA1 SHANK3 DST SHANK2 TJP1 MACF1 ARHGEF37	1.61e-03	220	185	8	IPR001452
Domain	Ig-like_fold	HSPG2 FLNA COL6A3 FLT4 IL31RA COL20A1 SPEG ICAM1 KIAA0319 SLAMF6 SHANK2 PTPRH NFATC1 NFATC2 NFATC4 NCR1	1.81e-03	706	185	16	IPR013783
Domain	Plectin	DST MACF1	1.98e-03	7	185	2	PF00681
Domain	Mob1_phocein	MOB1B MOB1A	1.98e-03	7	185	2	PF03637
Domain	Plectin_repeat	DST MACF1	1.98e-03	7	185	2	IPR001101
Domain	MOB_kinase_act_fam	MOB1B MOB1A	1.98e-03	7	185	2	IPR005301
Domain	-	MOB1B MOB1A	1.98e-03	7	185	2	1.20.140.30
Domain	Mob1_phocein	MOB1B MOB1A	1.98e-03	7	185	2	SM01388
Domain	PLEC	DST MACF1	1.98e-03	7	185	2	SM00250
Pathway	WP_CILIOPATHIES	USP9X BBIP1 CILK1 CEP164 WDR19 DNAAF5 GLIS2 CC2D2A TOPORS HYDIN	2.71e-05	184	150	10	M39880
Pathway	REACTOME_SIGNALING_BY_HIPPO	DVL2 TJP1 MOB1B MOB1A	5.23e-05	20	150	4	MM14813
Pathway	REACTOME_SIGNALING_BY_HIPPO	DVL2 TJP1 MOB1B MOB1A	5.23e-05	20	150	4	M591
Pathway	REACTOME_CALCINEURIN_ACTIVATES_NFAT	PPIA NFATC1 NFATC2	9.46e-05	9	150	3	M27106
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	ARHGAP32 CDC42EP4 TTC28 DOCK11 MAPT TEX2 CKAP5 INPP5F RRM2 MAP3K6 ARFGEF3 IFRD1 FAM117A TBC1D4 DST TIAM1 TJP1 MTOR CLMN AHNAK MACF1 AKAP13 KIF2A FOXK1 WNK3 AHNAK2 DOP1B	1.88e-13	861	187	27	36931259
Pubmed	Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis.	FLNA ZMPSTE24 SPTA1 U2AF2 CLSTN2 NDUFA9 APRT PPIA RUVBL2 ACTR2 NBAS FBP1 DST TXNDC5 AHNAK MACF1 AKAP13 HYDIN GOT2 AHNAK2 SYNCRIP TPI1	5.35e-10	807	187	22	30575818
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	FLNA USP9X CKAP5 U2AF2 PSMD11 CUL7 APRT PPIA RUVBL2 ACTR2 RIF1 DST TXNDC5 TJP1 AHNAK GLUD1 MACF1 KIF2A SPEN SF3B2 NUP153 GOT2 SYNCRIP TPI1	1.67e-09	1024	187	24	24711643
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	FLNA ARHGAP32 MAPT WFS1 TEX2 DTNA USP9X DVL2 CKAP5 PSMD11 NDUFA9 PPIA RUVBL2 SHANK3 RUFY3 ARFGEF3 SHANK2 TXNDC5 TJP1 GLUD1 GLUD2 MACF1 KIF2A TPI1	1.30e-08	1139	187	24	36417873
Pubmed	Tumor suppressor BAP1 nuclear import is governed by transportin-1.	FLNA USP9X CKAP5 MTMR1 U2AF2 PSMD11 APRT PPIA RUVBL2 ACTR2 DAP3 TBC1D4 DST NUDT5 TXNDC5 COPS8 AHNAK GLUD1 MACF1 SF3B2 FOXK1 NUP153 SYNCRIP TPI1	1.54e-08	1149	187	24	35446349
Pubmed	Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.	TTF2 TTC28 DOCK11 USP9X INPP5F CUL7 RUVBL2 RUFY3 TBC1D4 DST NFATC4 TJP1 MOB1B MOB1A KIF2A	2.28e-08	446	187	15	24255178
Pubmed	Functional proteomics mapping of a human signaling pathway.	TTF2 HSPG2 FLNA SUMF2 FLT4 CYP11A1 SMURF1 CILK1 U2AF2 PSMD11 PPP2R5E DST UBAC1 CSPG4 ANAPC2 MACF1 TOPORS	2.53e-08	591	187	17	15231748
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	TTC28 USP9X PEG3 CKAP5 SESN3 AIRE IDS RUFY3 RYR3 DMAP1 WDR19 PPP2R5E DST TIAM1 TJP1 GLUD1 MACF1 N4BP2L2 ZNF606 QKI PADI2 ST18 SF3B2 DOP1B SPATC1L	3.01e-08	1285	187	25	35914814
Pubmed	Large-scale proteomics and phosphoproteomics of urinary exosomes.	HSPG2 FLNA COL6A3 ZMPSTE24 ICAM1 SMURF1 ADGRV1 APRT PPIA ACTR2 FBP1 NUDT5 COPS8 AHNAK UBAC1 PKLR N4BP2L2 SPEN ITM2B PADI2 DOP1B TPI1	3.43e-08	1016	187	22	19056867
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	ACSL6 TTC28 SPEG PEG3 CKAP5 SMURF1 KIAA0319 ARFGEF3 PPP2R5E SEL1L3 MACF1 SPEN ST18 DOP1B	5.16e-08	407	187	14	12693553
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	ACSL6 FLNA ARHGAP32 MAPT WFS1 USP9X SPTA1 CKAP5 SMURF1 MTMR1 NDUFA9 SHANK3 ACTR2 RUFY3 PPP2R5E DST SHANK2 TJP1 CLMN GLUD1 GLUD2 MACF1 KIF2A GOT2 SYNCRIP TPI1	6.02e-08	1431	187	26	37142655
Pubmed	BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.	TTF2 ARHGAP32 ZMPSTE24 TTC28 DTNA USP9X DVL2 CKAP5 MTMR1 PPIA RUVBL2 DST NUDT5 AHNAK MACF1 SF3B2 NUP153 SYNCRIP	6.23e-08	708	187	18	39231216
Pubmed	The Hsp70-Hsp90 co-chaperone Hop/Stip1 shifts the proteostatic balance from folding towards degradation.	FLNA USP9X CKAP5 PSMD11 RRM2 RUVBL2 DNAAF5 RIF1 TBC1D4 TXNDC5 MTOR MOB1A KIF2A SF3B2 FOXK1 NUP153 SYNCRIP	7.58e-08	638	187	17	33239621
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	TTF2 FLNA CKAP5 U2AF2 PSMD11 NDUFA9 RRM2 PPIA RUVBL2 CCNT1 RIF1 TBC1D4 DST AHNAK LTN1 GSDMA AP1G2 MACF1 AKAP13 KIF2A SF3B2 GOT2 AHNAK2 SYNCRIP TPI1	8.07e-08	1353	187	25	29467282
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	PRUNE2 ARHGAP32 ADAMTS4 COL27A1 CILK1 ATG14 CUL7 SHANK3 FAT2 DNAH17 LTN1 HELZ2 MACF1 IRF2BPL ZNF606	8.41e-08	493	187	15	15368895
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	FLNA USP9X CKAP5 U2AF2 CUL7 ACTR2 RIF1 DST TJP1 MTOR AHNAK HELZ2 MACF1 SPEN SF3B2 NUP153 SYNCRIP	1.05e-07	653	187	17	22586326
Pubmed	Optimized fragmentation schemes and data analysis strategies for proteome-wide cross-link identification.	FLNA USP9X PSMD11 PPIA ACTR2 RIF1 TBC1D4 DST MTOR AHNAK MACF1 FRMPD3 SF3B2 AHNAK2 TPI1	2.57e-07	538	187	15	28524877
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	FLNA ZMPSTE24 COL20A1 DTNA PCDHGA3 SPTA1 U2AF2 TRIM43 ACTR2 FER1L6 TRIM43B DAP3 DST SHANK2 TJP1 AHNAK AVIL CSPG4 GLUD1 GLUD2 CC2D2A MACF1 SPEN PCDHGC3 SYNCRIP	2.67e-07	1442	187	25	35575683
Pubmed	Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking.	FLNA USP9X CKAP5 U2AF2 APRT RIF1 AHNAK HPS6 KIF2A SF3B2 AHNAK2 SYNCRIP	2.82e-07	332	187	12	32786267
Pubmed	A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling.	FLNA DTNA CKAP5 MTMR1 PSMD11 APRT DNAAF5 TXNDC5 PTPRH TJP1 MTOR GLUD1 LTN1 MOB1A QKI PADI2 SF3B2 FOXK1 NUP153 SYNCRIP	3.48e-07	974	187	20	28675297
Pubmed	Protein-protein interactions between large proteins: two-hybrid screening using a functionally classified library composed of long cDNAs.	ARHGAP32 TTC28 CKAP5 CUL7 KIAA0319 TBC1D4 DST MACF1	5.58e-07	130	187	8	12421765
Pubmed	Transcription factors of the NFAT family: regulation and function.	NFATC1 NFATC2 NFATC4	6.09e-07	4	187	3	9143705
Pubmed	Nuclear factor of activated T cells is activated in the endothelium of retinal microvessels in diabetic mice.	NFATC1 NFATC2 NFATC4	6.09e-07	4	187	3	25918731
Pubmed	NFAT isoforms play distinct roles in TNFα-induced retinal leukostasis.	NFATC1 NFATC2 NFATC4	6.09e-07	4	187	3	26527057
Pubmed	HIV-1 gp120 induces NFAT nuclear translocation in resting CD4+ T-cells.	NFATC1 NFATC2 NFATC4	6.09e-07	4	187	3	16260021
Pubmed	Alternative splicing and expression of human and mouse NFAT genes.	NFATC1 NFATC2 NFATC4	6.09e-07	4	187	3	18675896
Pubmed	The transcription factor nuclear factor of activated T cells c3 modulates the function of macrophages in sepsis.	NFATC1 NFATC2 NFATC4	6.09e-07	4	187	3	24970700
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	BDP1 TTC28 DTNA USP9X CUL7 RUVBL2 RUFY3 ARFGEF3 TBC1D4 NUDT5 NFATC1 MACF1 TOPORS SPEN FOXK1	7.86e-07	588	187	15	38580884
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	TTF2 FLNA DVL2 CKAP5 PPIA CCNT1 RIF1 DST NUDT5 TJP1 CLMN AHNAK GLUD1 SUGP1 MACF1 SF3B2 NUP153 AHNAK2 TPI1	7.98e-07	934	187	19	33916271
Pubmed	LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling.	TTF2 FLNA SUMF2 WFS1 USP9X DVL2 PSMD11 NDUFA9 ARFGEF3 DNAAF5 IFRD1 PPP2R5E LPCAT2 MTOR ANAPC2 QKI ITM2B WNK3 NUP153	9.06e-07	942	187	19	31073040
Pubmed	Interactome analyses revealed that the U1 snRNP machinery overlaps extensively with the RNAP II machinery and contains multiple ALS/SMA-causative proteins.	TEX2 USP9X U2AF2 RUVBL2 CCNT1 RIF1 GSDMA SF3B2 GOT2 SYNCRIP	9.16e-07	244	187	10	29884807
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	TTF2 DVL2 CKAP5 MTMR1 CUL7 PARS2 DMAP1 RIF1 IFRD1 TBC1D4 TXNDC5 NFATC1 NFATC2 NFATC4 GSDMA SPEN SF3B2 FOXK1	1.01e-06	857	187	18	25609649
Pubmed	Faciogenital Dysplasia 5 supports cancer stem cell traits in basal-like breast cancer by enhancing EGFR stability.	FLNA SMURF1 PSMD11 DST TJP1 AHNAK MACF1 GOT2 TPI1	1.03e-06	191	187	9	33762435
Pubmed	Comparative interactome analysis of α-arrestin families in human and Drosophila.	DTNA USP9X SMURF1 U2AF2 INPP5F CUL7 RUVBL2 ARFGEF3 CCNT1 LTN1 SPEN	1.17e-06	313	187	11	38270169
Pubmed	Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.	FLNA CKAP5 U2AF2 ARHGAP11A NDUFA9 PPIA RUVBL2 ACTR2 DAP3 DST TJP1 AHNAK GLUD1 HELZ2 GSDMA KIF2A TOPORS SPEN SF3B2 NUP153 SYNCRIP TPI1	1.27e-06	1257	187	22	36526897
Pubmed	Impaired OTUD7A-dependent Ankyrin regulation mediates neuronal dysfunction in mouse and human models of the 15q13.3 microdeletion syndrome.	ACSL6 MTMR1 SHANK3 ARFGEF3 DAP3 SHANK2 TJP1 MACF1 ITM2B	1.33e-06	197	187	9	36604605
Pubmed	Early growth response proteins (EGR) and nuclear factors of activated T cells (NFAT) form heterodimers and regulate proinflammatory cytokine gene expression.	NFATC1 NFATC2 EGR4	1.52e-06	5	187	3	12560487
Pubmed	Human immunodeficiency virus type-1 tat enhances interleukin-2 promoter activity through synergism with phorbol ester and calcium-mediated activation of the NF-AT cis-regulatory motif.	NFATC1 NFATC2 NFATC4	1.52e-06	5	187	3	7999066
Pubmed	Generic signals and specific outcomes: signaling through Ca2+, calcineurin, and NF-AT.	NFATC1 NFATC2 NFATC4	1.52e-06	5	187	3	10089876
Pubmed	NFAT: ubiquitous regulator of cell differentiation and adaptation.	NFATC1 NFATC2 NFATC4	1.52e-06	5	187	3	11877454
Pubmed	Down syndrome critical region-1 is a transcriptional target of nuclear factor of activated T cells-c1 within the endocardium during heart development.	NFATC1 NFATC2 NFATC4	1.52e-06	5	187	3	17693409
Pubmed	Expression of human endogenous retrovirus type K (HML-2) is activated by the Tat protein of HIV-1.	NFATC1 NFATC2 NFATC4	1.52e-06	5	187	3	22593154
Pubmed	Network organization of the huntingtin proteomic interactome in mammalian brain.	ACSL6 MAPT WFS1 SPTA1 MTMR1 U2AF2 NDUFA9 DST MTOR GLUD1 GLUD2 PKLR KIF2A GOT2 SYNCRIP	1.54e-06	621	187	15	22794259
Pubmed	LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy.	FLNA CKAP5 NBAS TIAM1 MTOR AHNAK LTN1 MROH7 AKAP13	1.64e-06	202	187	9	33005030
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	PRUNE2 BDP1 MAPT DTNA ABHD2 SMURF1 CILK1 U2AF2 ADGRV1 XRCC2 ARFGEF3 DNAAF5 IFRD1 TBC1D4 PPP4C SHANK2 NFATC1 TJP1 CLMN AOPEP SEL1L3 MACF1 AKAP13 ARHGEF37	1.70e-06	1489	187	24	28611215
Pubmed	USP10 deubiquitinates Tau, mediating its aggregation.	MAPT CEP164 DNAAF5 FOXK1	2.33e-06	18	187	4	35987808
Pubmed	Proximity labeling of endogenous RICTOR identifies mTOR complex 2 regulation by ADP ribosylation factor ARF1.	FLNA CKAP5 U2AF2 RUVBL2 CCNT1 TJP1 MTOR AHNAK SF3B2	2.73e-06	215	187	9	35973513
Pubmed	Increased dosage of DYRK1A and DSCR1 delays neuronal differentiation in neocortical progenitor cells.	NFATC1 NFATC2 NFATC4	3.02e-06	6	187	3	24352425
Pubmed	A strategy for probing the function of noncoding RNAs finds a repressor of NFAT.	NFATC1 NFATC2 NFATC4	3.02e-06	6	187	3	16141075
Pubmed	Nuclear factor of activated T cells (NFAT) proteins repress canonical Wnt signaling via its interaction with Dishevelled (Dvl) protein and participate in regulating neural progenitor cell proliferation and differentiation.	DVL2 NFATC1 NFATC4	3.02e-06	6	187	3	21880741
Pubmed	Regulation of T cell activation by HIV-1 accessory proteins: Vpr acts via distinct mechanisms to cooperate with Nef in NFAT-directed gene expression and to promote transactivation by CREB.	NFATC1 NFATC2 NFATC4	3.02e-06	6	187	3	12788643
Pubmed	Cyclosporin A sensitivity of the HIV-1 long terminal repeat identifies distinct p56lck-dependent pathways activated by CD4 triggering.	NFATC1 NFATC2 NFATC4	3.02e-06	6	187	3	8814265
Pubmed	The lncRNA NRON modulates HIV-1 replication in a NFAT-dependent manner and is differentially regulated by early and late viral proteins.	NFATC1 NFATC2 NFATC4	3.02e-06	6	187	3	25728138
Pubmed	Human immunodeficiency virus type 1 Tat increases cooperation between AP-1 and NFAT transcription factors in T cells.	NFATC1 NFATC2 NFATC4	3.02e-06	6	187	3	16690925
Pubmed	Systematic Analysis of Human Protein Phosphatase Interactions and Dynamics.	HTR2C CKAP5 PSMD11 RUVBL2 DMAP1 RIF1 PPP2R5E PPP4C PTPRH GLUD1 SF3B2 GOT2 DOP1B TPI1	3.05e-06	573	187	14	28330616
Pubmed	Cell cycle-dependent phosphorylation regulates RECQL4 pathway choice and ubiquitination in DNA double-strand break repair.	DTNA USP9X PEG3 U2AF2 IFT46 PSMD11 NDUFA9 PPIA RUVBL2 ACTR2 PARS2 CCNT1 DAP3 PPP2R5E TBC1D4 TXNDC5 COPS8 ANAPC2 KIF2A SF3B2 SYNCRIP TPI1	3.36e-06	1335	187	22	29229926
Pubmed	Ex vivo Quantitative Proteomic Analysis of Serotonin Transporter Interactome: Network Impact of the SERT Ala56 Coding Variant.	ACSL6 ARHGAP32 WFS1 DTNA USP9X SPTA1 ADGRV1 NDUFA9 PPIA SHANK3 ACTR2 MACF1	4.17e-06	430	187	12	32581705
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	ARHGAP32 DTNA USP9X MTMR1 PSMD11 CUL7 RIF1 PPP2R5E TBC1D4 PPP4C NUDT5 TXNDC5 PTPRH TIAM1 TJP1 AHNAK LTN1 MOB1A NUP153	4.33e-06	1049	187	19	27880917
Pubmed	Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells.	FLNA USP9X DVL2 CKAP5 PSMD11 RUVBL2 DAP3 BPNT1 NUDT5 TXNDC5 TJP1 MTOR AHNAK GLUD1 GSDMA IRF2BPL QKI SF3B2 FOXK1 GOT2 AHNAK2 TPI1	4.89e-06	1367	187	22	32687490
Pubmed	NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21.	NFATC1 NFATC2 NFATC4	5.27e-06	7	187	3	16554754
Pubmed	Scleraxis and NFATc regulate the expression of the pro-alpha1(I) collagen gene in tendon fibroblasts.	NFATC1 NFATC2 NFATC4	5.27e-06	7	187	3	17430895
Pubmed	NFAT binding and regulation of T cell activation by the cytoplasmic scaffolding Homer proteins.	NFATC1 NFATC2 NFATC4	5.27e-06	7	187	3	18218901
Pubmed	Calcium/NFAT signalling promotes early nephrogenesis.	NFATC1 NFATC2 NFATC4	5.27e-06	7	187	3	21295565
Pubmed	Extracellular HIV-Tat induces cyclooxygenase-2 in glial cells through activation of nuclear factor of activated T cells.	NFATC1 NFATC2 NFATC4	5.27e-06	7	187	3	18097055
Pubmed	CLEC16A interacts with retromer and TRIM27, and its loss impairs endosomal trafficking and neurodevelopment.	TTF2 TTC28 PSMD11 MAP3K6 ACTR2 PARS2 DNAAF5 RIF1 NFATC1 MTOR HPS6 GLUD1 GLUD2 KIF2A	5.78e-06	606	187	14	36538041
Pubmed	Quantitative Proteomics Links the LRRC59 Interactome to mRNA Translation on the ER Membrane.	FLNA ZMPSTE24 WFS1 DVL2 CKAP5 NBAS TXNDC5 LPCAT2 CLMN GLUD1 NUP153	6.62e-06	375	187	11	32788342
Pubmed	Characterization of the EGFR interactome reveals associated protein complex networks and intracellular receptor dynamics.	USP9X ARFGEF3 DNAAF5 PPP2R5E MTOR LTN1 AP1G2 DOP1B	7.21e-06	183	187	8	23956138
Pubmed	Systematically defining selective autophagy receptor-specific cargo using autophagosome content profiling.	FLNA SUMF2 ZMPSTE24 PSMD11 APRT RRM2 PPIA ACTR2 DMAP1 DNAAF5 TBC1D4 FADS3 DST TXNDC5 TJP1 AHNAK MOB1A MACF1 AKAP13 GOT2 SYNCRIP	7.44e-06	1297	187	21	33545068
Pubmed	Targeted disruption of NFATc3, but not NFATc4, reveals an intrinsic defect in calcineurin-mediated cardiac hypertrophic growth.	NFATC1 NFATC2 NFATC4	8.40e-06	8	187	3	12370307
Pubmed	Interaction of HIV gp120 and anti-CD4 antibodies with the CD4 molecule on human CD4+ T cells inhibits the binding activity of NF-AT, NF-kappa B and AP-1, three nuclear factors regulating interleukin-2 gene enhancer activity.	NFATC1 NFATC2 NFATC4	8.40e-06	8	187	3	7957556
Pubmed	Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones.	FLNA USP9X CKAP5 U2AF2 NDUFA9 PPIA RUVBL2 DAP3 RIF1 TBC1D4 TXNDC5 TJP1 AHNAK GLUD1 MACF1 AKAP13 KIF2A SF3B2 FOXK1 AHNAK2 SYNCRIP TPI1	8.40e-06	1415	187	22	28515276
Pubmed	SLFN11 promotes CDT1 degradation by CUL4 in response to replicative DNA damage, while its absence leads to synthetic lethality with ATR/CHK1 inhibitors.	BDP1 FLNA COL27A1 PSMD11 RIF1 TIAM1 LTN1 HELZ2 NUP153	9.26e-06	250	187	9	33536335
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	FLNA USP9X CKAP5 U2AF2 PSMD11 PPIA RUVBL2 ACTR2 DAP3 RIF1 TXNDC5 MTOR GLUD1 CC2D2A KIF2A SPEN ITM2B SF3B2 NUP153 GOT2 SYNCRIP TPI1	9.38e-06	1425	187	22	30948266
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	FLNA DOCK11 MAPT CKAP5 U2AF2 RUVBL2 ACTR2 NUDT5 LPCAT2 TJP1 AHNAK MACF1 AKAP13 SPEN AHNAK2	9.78e-06	724	187	15	36232890
Pubmed	High-sensitivity profiling of SARS-CoV-2 noncoding region-host protein interactome reveals the potential regulatory role of negative-sense viral RNA.	A1CF U2AF2 PSMD11 RUVBL2 DAP3 HELZ2 SUGP1 KIF2A QKI SF3B2 SYNCRIP TPI1	9.98e-06	469	187	12	37314180
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	ARHGAP32 TTC28 USP9X NR4A3 ATG14 NDUFA9 FER1L6 WDR19 DAP3 DNAH12 TXNDC5 SUGP1 SPEN AHNAK2	1.03e-05	638	187	14	31182584
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	TTC28 MAPT CECR2 DVL2 U2AF2 CLSTN2 CUL7 RUVBL2 PARS2 DMAP1 CCNT1 DAP3 PPP2R5E LTN1 MACF1 TOPORS PADI2 FOXK1 SPATC1L	1.04e-05	1116	187	19	31753913
Pubmed	Nuclear import of histone deacetylase 5 by requisite nuclear localization signal phosphorylation.	FLNA USP9X PSMD11 PPIA RUVBL2 GLUD1 SF3B2 GOT2 TPI1	1.19e-05	258	187	9	21081666
Pubmed	The kinase LRRK2 is a regulator of the transcription factor NFAT that modulates the severity of inflammatory bowel disease.	CYP11A1 PSMD11 NFATC2	1.25e-05	9	187	3	21983832
Pubmed	Defining the Protein-Protein Interaction Network of the Human Protein Tyrosine Phosphatase Family.	DOCK11 WFS1 DTNA USP9X MTMR1 NDUFA9 APRT PPIA DNAAF5 DAP3 PPP4C TXNDC5 COPS8 GLUD1 LTN1 KIF2A QKI	1.28e-05	931	187	17	27432908
Pubmed	A high-throughput approach for measuring temporal changes in the interactome.	PRUNE2 FLNA USP9X DVL2 PSMD11 PPIA RUVBL2 ACTR2 DNAAF5 PPP2R5E TBC1D4 PPP4C NUDT5 TXNDC5 COPS8 MTOR AHNAK MACF1 IRF2BPL FOXK1 AHNAK2 SYNCRIP	1.29e-05	1455	187	22	22863883
Pubmed	Comparative proximity biotinylation implicates the small GTPase RAB18 in sterol mobilization and biosynthesis.	FLNA TEX2 DVL2 CKAP5 NBAS FADS3 DST NUDT5 LPCAT2 TJP1 AHNAK NUP153 AHNAK2	1.39e-05	568	187	13	37774976
Pubmed	The RNA binding protein MEX3A promotes tumor progression of breast cancer by post-transcriptional regulation of IGFBP4.	FLNA USP9X CKAP5 DST AHNAK HELZ2 MACF1 IRF2BPL FOXK1 AHNAK2	1.40e-05	332	187	10	37433992
Pubmed	MARK3-mediated phosphorylation of ARHGEF2 couples microtubules to the actin cytoskeleton to establish cell polarity.	MAPT CKAP5 TBC1D4 MACF1 KIF2A	1.42e-05	57	187	5	29089450
Pubmed	Chromatin accessibility complex subunit 1 enhances tumor growth by regulating the oncogenic transcription of YAP in breast and cervical cancer.	USP9X CKAP5 NUDT5 TJP1 SF3B2	1.42e-05	57	187	5	38223760
Pubmed	SARS-CoV-2 Nsp6 damages Drosophila heart and mouse cardiomyocytes through MGA/MAX complex-mediated increased glycolysis.	FLNA ZMPSTE24 MANBA USP9X CKAP5 PSMD11 NDUFA9 PPIA ACTR2 DNAAF5 RIF1 MTOR LTN1 SF3B2	1.43e-05	657	187	14	36180527
Pubmed	Substrate and functional diversity of lysine acetylation revealed by a proteomics survey.	CHDH NDUFA9 PPIA CCNT1 GLUD1 GLUD2 GOT2 TPI1	1.53e-05	203	187	8	16916647
Pubmed	ISG15 Connects Autophagy and IFN-γ-Dependent Control of Toxoplasma gondii Infection in Human Cells.	FLNA ZMPSTE24 TTC28 U2AF2 PPIA RUVBL2 TJP1 AHNAK AHNAK2	1.61e-05	268	187	9	33024031
Pubmed	Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells.	USP9X CKAP5 U2AF2 NDUFA9 RUVBL2 ACTR2 CCNT1 NUDT5 SUGP1 IRF2BPL SPEN FOXK1 SYNCRIP TPI1	1.64e-05	665	187	14	30457570
Pubmed	Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing.	FLNA U2AF2 PPIA RUVBL2 CCNT1 AHNAK SF3B2 NUP153 SYNCRIP	1.76e-05	271	187	9	32433965
Pubmed	Spatial and temporal regulation of coronary vessel formation by calcineurin-NFAT signaling.	NFATC1 NFATC2 NFATC4	1.79e-05	10	187	3	19710169
Pubmed	FOXC2 controls formation and maturation of lymphatic collecting vessels through cooperation with NFATc1.	FLT4 NFATC1 CSPG4	1.79e-05	10	187	3	19398761
Pubmed	Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice.	TTF2 CKAP5 U2AF2 PSMD11 RUVBL2 ACTR2 RIF1 AHNAK ANAPC2 MACF1 SF3B2 NUP153 SYNCRIP	1.79e-05	582	187	13	20467437
Pubmed	Fibril treatment changes protein interactions of tau and α-synuclein in human neurons.	FLNA MAPT USP9X DVL2 INPP5F RUVBL2 RUFY3 DST TJP1 AHNAK MACF1 KIF2A	1.81e-05	498	187	12	36634849
Pubmed	Cullin 1 (CUL1) Promotes Primary Ciliogenesis through the Induction of Ubiquitin-Proteasome-Dependent Dvl2 Degradation.	COL27A1 DVL2 ADGRV1 FAT2 PKLR MACF1 FOXK1	1.95e-05	152	187	7	34299191
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	ARHGAP32 DOCK11 USP9X DVL2 CKAP5 PPIA SHANK3 KIAA0319 DST SHANK2 TJP1 MTOR MACF1 KIF2A FRMPD3 WNK3 NUP153	1.96e-05	963	187	17	28671696
Pubmed	In silico APC/C substrate discovery reveals cell cycle-dependent degradation of UHRF1 and other chromatin regulators.	TTF2 FLNA FLT4 USP9X SPEG CKAP5 U2AF2 PSMD11 RRM2 RUVBL2 DAP3 IFRD1 ANAPC2 QKI SF3B2 NUP153 SYNCRIP	2.18e-05	971	187	17	33306668
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	CECR2 SMURF1 MTMR1 U2AF2 PPIA RUVBL2 PARS2 DMAP1 DAP3 DST TJP1 HELZ2 SUGP1 MACF1 KIF2A SPEN SF3B2 SYNCRIP	2.43e-05	1082	187	18	38697112
Pubmed	Functional synergy of a human-specific and an ape-specific metabolic regulator in human neocortex development.	ARHGAP11A GLUD1 GLUD2	2.45e-05	11	187	3	38658571
Pubmed	Hydroxylation of 5-methylcytosine by TET1 promotes active DNA demethylation in the adult brain.	A1CF APOBEC2 SYNCRIP	2.45e-05	11	187	3	21496894
Interaction	YWHAQ interactions	FLNA EGLN3 ARHGAP32 TTC28 DOCK11 MAPT SPEG SPTA1 DVL2 SMURF1 PSMD11 INPP5F CUL7 RUVBL2 SHANK3 ACTR2 FAM117A PPP2R5E TBC1D4 FBP1 DST TXNDC5 TIAM1 NFATC1 NFATC2 NFATC4 TJP1 MTOR MACF1 AKAP13 FOXK1 TPI1	1.02e-08	1118	186	32	int:YWHAQ
Interaction	YWHAH interactions	ARHGAP32 CDC42EP4 TTC28 DOCK11 MAPT TEX2 SPEG CKAP5 INPP5F RRM2 MAP3K6 ACTR2 ARFGEF3 FAM117A TBC1D4 DST TIAM1 TJP1 MTOR CLMN AHNAK MOB1A CC2D2A MACF1 AKAP13 KIF2A FOXK1 WNK3 AHNAK2 DOP1B	9.53e-08	1102	186	30	int:YWHAH
Interaction	CUL7 interactions	FLNA ARHGAP32 PCDHGA3 CECR2 COL27A1 U2AF2 PSMD11 CUL7 APRT PPIA RUVBL2 ACTR2 RIF1 TXNDC5 TJP1 AHNAK GLUD1 MROH7 MACF1 KIF2A SPEN SF3B2 GOT2 SYNCRIP TPI1	2.75e-07	845	186	25	int:CUL7
Interaction	OBSL1 interactions	PRUNE2 FLNA EGLN3 ARHGAP32 CECR2 U2AF2 PSMD11 CUL7 PPIA RUVBL2 ACTR2 RIF1 DST TXNDC5 NFATC1 TJP1 AHNAK ANAPC2 MACF1 KIF2A SPEN SF3B2 NUP153 SYNCRIP TPI1	9.14e-07	902	186	25	int:OBSL1
Interaction	DVL2 interactions	EGLN3 MAPT USP9X COL27A1 DVL2 SMURF1 U2AF2 ATG14 PSMD11 ADGRV1 NDUFA9 PPIA NBAS FAT2 UBAC1 PKLR MACF1 KIF2A FOXK1	1.05e-06	557	186	19	int:DVL2
Interaction	YWHAG interactions	FLNA ARHGAP32 TTC28 DOCK11 MAPT SPEG DVL2 CKAP5 INPP5F CUL7 RRM2 MAP3K6 RUVBL2 SHANK3 ACTR2 IFRD1 FAM117A TBC1D4 DST TXNDC5 TIAM1 NFATC2 TJP1 MTOR CLMN MACF1 AKAP13 KIF2A FOXK1 AHNAK2	1.32e-06	1248	186	30	int:YWHAG
Interaction	YWHAZ interactions	BDP1 EGLN3 ARHGAP32 TTC28 DOCK11 MAPT TEX2 SPEG SPTA1 CKAP5 MTMR1 U2AF2 INPP5F CUL7 SHANK3 ACTR2 TBC1D4 DST TIAM1 NFATC2 NFATC4 TJP1 MTOR GSDMA MACF1 AKAP13 KIF2A PADI2 SF3B2 FOXK1 TPI1	1.38e-06	1319	186	31	int:YWHAZ
Interaction	STIP1 interactions	FLNA EGLN3 MAPT TEX2 USP9X CKAP5 U2AF2 PSMD11 CUL7 RRM2 RUVBL2 ACTR2 DNAAF5 RIF1 TBC1D4 TXNDC5 MTOR AHNAK ANAPC2 MOB1A KIF2A SF3B2 FOXK1 NUP153 SYNCRIP TPI1	1.99e-06	1006	186	26	int:STIP1
Interaction	SUMO2 interactions	FLNA EGLN3 HNF1B USP9X CKAP5 U2AF2 APRT RIF1 DST AHNAK HPS6 ANAPC2 KIF2A TOPORS SF3B2 NUP153 AHNAK2 SYNCRIP TPI1	2.50e-06	591	186	19	int:SUMO2
Interaction	RPA4 interactions	FLNA ZMPSTE24 TTC28 DVL2 U2AF2 RUVBL2 ARFGEF3 RIF1 DST TJP1 MTOR AHNAK SF3B2 NUP153 GOT2 SYNCRIP	4.86e-06	452	186	16	int:RPA4
Interaction	FBXO42 interactions	BDP1 TTC28 DTNA USP9X SMURF1 RUVBL2 RUFY3 ARFGEF3 TBC1D4 PPP4C COPS8 MACF1	5.43e-06	259	186	12	int:FBXO42
Interaction	METTL14 interactions	FLNA COL6A3 ERICH3 CHDH CKAP5 U2AF2 PPIA RYR3 TXNDC5 AHNAK HPS6 GLUD1 GLUD2 MSL3 SF3B2 GOT2 SYNCRIP	1.74e-05	558	186	17	int:METTL14
Interaction	AGR2 interactions	FLNA ZMPSTE24 SPTA1 U2AF2 CLSTN2 NDUFA9 APRT PPIA RUVBL2 ACTR2 NBAS FBP1 DST TXNDC5 AHNAK MACF1 AKAP13 HYDIN GOT2 PTTG2 AHNAK2 SYNCRIP TPI1	1.78e-05	934	186	23	int:AGR2
Interaction	YWHAB interactions	EGLN3 ARHGAP32 TTC28 DOCK11 MAPT SPEG DVL2 INPP5F CUL7 PPIA SHANK3 ACTR2 FAM117A TBC1D4 DST TIAM1 NFATC2 TJP1 MTOR MACF1 AKAP13 KIF2A FOXK1 AHNAK2	2.19e-05	1014	186	24	int:YWHAB
Interaction	DDX42 interactions	U2AF2 CUL7 ARHGAP11A RUVBL2 CCNT1 TIAM1 GLUD1 AKAP13 SF3B2 SYNCRIP	2.44e-05	208	186	10	int:DDX42
Interaction	GPHN interactions	EGLN3 ARHGAP32 USP9X PSMD11 PPIA RUFY3 TJP1 MTOR	3.51e-05	134	186	8	int:GPHN
Interaction	U2AF2 interactions	FLNA MAPT DVL2 U2AF2 CUL7 PPIA RUVBL2 DAP3 TJP1 AHNAK GLIS2 GLUD1 SUGP1 QKI SF3B2 GOT2 SYNCRIP TPI1	3.52e-05	651	186	18	int:U2AF2
Interaction	UBXN6 interactions	TTF2 DVL2 SMURF1 CUL7 MAP3K6 RUVBL2 DNAAF5 TBC1D4 DST TXNRD3 N4BP2L2 FOXK1	5.15e-05	325	186	12	int:UBXN6
Interaction	KCNA3 interactions	TTF2 ARHGAP32 ZMPSTE24 TTC28 DTNA USP9X COL27A1 DVL2 CKAP5 MTMR1 PPIA RUVBL2 TBC1D4 DST NUDT5 AHNAK MACF1 SPEN SF3B2 NUP153 SYNCRIP	5.72e-05	871	186	21	int:KCNA3
Interaction	CFL1 interactions	FLNA EGLN3 MAPT DVL2 SMURF1 U2AF2 CUL7 PPIA ACTR2 DST SPEN GOT2 TPI1	6.10e-05	384	186	13	int:CFL1
Interaction	COL27A1 interactions	COL27A1 DVL2 CUL7	6.24e-05	9	186	3	int:COL27A1
Interaction	DLG4 interactions	ACSL6 ARHGAP32 HTR2C MTMR1 PPIA SHANK3 DAP3 SHANK2 TIAM1 GLUD1 MACF1 KIF2A FRMPD3 ITM2B	7.68e-05	449	186	14	int:DLG4
Interaction	SFN interactions	ARHGAP32 DOCK11 MAPT TEX2 INPP5F ARHGAP11A MAP3K6 RUVBL2 TBC1D4 DST TIAM1 TJP1 MTOR CLMN MACF1 AKAP13 KIF2A AHNAK2	7.72e-05	692	186	18	int:SFN
Interaction	CTTN interactions	FLNA EGLN3 MAPT CKAP5 SMURF1 SHANK3 ACTR2 CCNT1 SHANK2 TJP1 AHNAK GLUD1 SF3B2 SYNCRIP	7.86e-05	450	186	14	int:CTTN
Interaction	PFN1 interactions	TTF2 TEX2 INPP5F CUL7 ACTR2 CCNT1 NBAS TJP1 MACF1 AKAP13 KIF2A SF3B2 AHNAK2 DOP1B TPI1	8.00e-05	509	186	15	int:PFN1
Interaction	HAPSTR1 interactions	TTC28 USP9X CKAP5 MTMR1 U2AF2 PSMD11 ADGRV1 DAP3 BPNT1 RIF1 IFRD1 PPP2R5E TBC1D4 PPP4C KIF2A ITM2B SF3B2 NUP153 CYTH4 DOP1B	8.60e-05	829	186	20	int:HAPSTR1
Interaction	LRRC31 interactions	FLNA CKAP5 NBAS TIAM1 MTOR AHNAK LTN1 MROH7 AKAP13	1.25e-04	205	186	9	int:LRRC31
Interaction	DCAF15 interactions	FLNA EGLN3 SPTA1 TRAIP CKAP5 PPIA RUFY3 TJP1 DNAH9 SPATC1L	1.34e-04	255	186	10	int:DCAF15
Interaction	SYNGAP1 interactions	ARHGAP32 PDE6B MAPT PPIA RUVBL2 SHANK3 RUFY3 SHANK2 MTOR GLUD1 AKAP13	1.38e-04	307	186	11	int:SYNGAP1
Interaction	PDIA3 interactions	FLNA FLT4 MAPT WFS1 DTNA U2AF2 CUL7 IDS PPIA PTPRH MTOR AHNAK HYDIN TPI1	1.42e-04	476	186	14	int:PDIA3
Interaction	DNAH11 interactions	DVL2 DNAH17 GOT2	1.60e-04	12	186	3	int:DNAH11
GeneFamily	Nuclear factors of activated T-cells	NFATC1 NFATC2 NFATC4	3.85e-06	5	133	3	665
GeneFamily	PDZ domain containing	DVL2 SHANK3 SHANK2 TIAM1 TJP1 AHNAK FRMPD3 AHNAK2	1.67e-05	152	133	8	1220
GeneFamily	Dyneins, axonemal	DNAH12 DNAH17 DNAH9	2.45e-04	17	133	3	536
GeneFamily	MOB kinase activators\|STRIPAK complex	MOB1B MOB1A	1.10e-03	7	133	2	647
GeneFamily	Blood group antigens\|CD molecules\|Proteoglycans	HSPG2 CSPG4	1.10e-03	7	133	2	570
GeneFamily	EF-hand domain containing\|Plakins	DST MACF1	1.46e-03	8	133	2	939
GeneFamily	Phosphoinositide phosphatases	MTMR1 INPP5F BPNT1	1.65e-03	32	133	3	1079
GeneFamily	BRICHOS domain containing	CNMD ITM2B	1.87e-03	9	133	2	457
GeneFamily	INO80 complex \|SRCAP complex	RUVBL2 DMAP1	1.87e-03	9	133	2	1329
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	TTC28 USP9X CKAP5 INPP5F ARHGAP11A NBAS RIF1 IFRD1 PPP2R5E DST TIAM1 LTN1 MACF1 N4BP2L2 AKAP13 KIF2A QKI SPEN NUP153 DOP1B	3.26e-06	856	186	20	M4500
Coexpression	MURARO_PANCREAS_DELTA_CELL	ERICH3 PEG3 SESN3 SEC11C ADGRV1 INPP5F IDS RUFY3 ARFGEF3 APOBEC2	1.28e-05	250	186	10	M39170
Coexpression	GSE17721_CTRL_VS_GARDIQUIMOD_4H_BMDC_UP	TTC28 WFS1 SPEG MTMR1 FAM117A ANAPC2 FKBP7 ITM2B SF3B2	1.38e-05	200	186	9	M3780
Coexpression	FAN_EMBRYONIC_CTX_EX_4_EXCITATORY_NEURON	ERICH3 SPEG RYR3 ARFGEF3 FADS3 AP1G2 HYDIN FOXK1	2.57e-05	166	186	8	M39026
Coexpression	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN	COL6A3 ADAMTS4 MAPT COL20A1 TEX2 DTNA SPEG COL27A1 SMURF1 BBIP1 SESN3 CILK1 RUFY3 DST CLMN AOPEP GLIS2 ENTPD5 FKBP7 QKI PADI2	3.94e-05	1102	186	21	M2369
Coexpression	BROWNE_HCMV_INFECTION_48HR_DN	PRUNE2 HSPG2 FLNA MANBA DTNA APRT RUFY3 RIF1 FADS3 ABCA6 NFATC4 TJP1 NCR1	4.37e-05	482	186	13	M12144
Coexpression	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN	COL6A3 ADAMTS4 MAPT COL20A1 TEX2 DTNA SPEG COL27A1 SMURF1 BBIP1 SESN3 CILK1 RUFY3 DST CLMN AOPEP GLIS2 ENTPD5 FKBP7 QKI PADI2	5.23e-05	1124	186	21	MM1070
Coexpression	HEVNER_CORTEX_RADIAL_GLIA_PROGENITORS	TTF2 ADGRV1 RRM2 TBC1D4 NUDT5 TXNDC5 NFATC4 TJP1 MSL3 MOB1A PARPBP QKI	6.52e-05	432	186	12	MM419
Coexpression	DESCARTES_MAIN_FETAL_ERYTHROBLASTS	ACSL6 SPTA1 ATG14 RRM2 FAM117A MOB1B UBAC1 PKLR PARPBP	6.76e-05	245	186	9	M40073
Coexpression	GSE37416_0H_VS_12H_F_TULARENSIS_LVS_NEUTROPHIL_UP	ZMPSTE24 FAM117A NUDT5 LPCAT2 GLUD1 IRF2BPL TOPORS PTTG2	8.61e-05	197	186	8	M5347
Coexpression	GSE22025_PROGESTERONE_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_UP	COL6A3 MTMR1 ATG14 INPP5F TIAM1 UBAC1 MSL3 MACF1	9.24e-05	199	186	8	M8381
Coexpression	GSE29618_PDC_VS_MDC_DAY7_FLU_VACCINE_UP	EGLN3 TEX2 PCDHGA3 BBIP1 WDR19 TBC1D4 SEL1L3 AHNAK2	9.24e-05	199	186	8	M4970
Coexpression	GSE16385_ROSIGLITAZONE_IL4_VS_IFNG_TNF_STIM_MACROPHAGE_UP	COL6A3 INPP5F IDS PPP2R5E TIAM1 LTN1 AP1G2 N4BP2L2	9.57e-05	200	186	8	M8030
Coexpression	GSE8685_IL2_ACT_IL2_STARVED_VS_IL15_ACT_IL2_STARVED_CD4_TCELL_UP	DOCK11 MTMR1 ACTR2 TIAM1 ANAPC2 HELZ2 AP1G2 NCR1	9.57e-05	200	186	8	M331
Coexpression	GSE24142_DN2_VS_DN3_THYMOCYTE_FETAL_UP	FLNA EGLN3 PSMD11 XRCC2 MAP3K6 GLIS2 KIF2A SYNCRIP	9.57e-05	200	186	8	M4574
Coexpression	GSE17721_CTRL_VS_LPS_24H_BMDC_DN	ZMPSTE24 TTC28 MAP3K6 RUVBL2 CEP164 SLAMF6 NUDT5 TXNDC5	9.57e-05	200	186	8	M3704
Coexpression	GSE16522_ANTI_CD3CD28_STIM_VS_UNSTIM_MEMORY_CD8_TCELL_DN	NUDT14 SESN3 MTMR1 SEC11C IDS CEP164 UBAC1 ITM2B	9.57e-05	200	186	8	M3664
Coexpression	GSE7852_LN_VS_FAT_TREG_UP	EXO5 TTC28 SESN3 INPP5F RUVBL2 PARS2 TBC1D4 SUGP1	9.57e-05	200	186	8	M5739
Coexpression	GSE7460_CD8_TCELL_VS_CD4_TCELL_ACT_DN	SUMF2 EXO5 WFS1 AIRE IFT46 DAP3 TIAM1 FOXK1	9.57e-05	200	186	8	M5689
Coexpression	HE_LIM_SUN_FETAL_LUNG_C4_ILC2_CELL	EGLN3 CHDH NR4A3 TIAM1 LPCAT2 SEL1L3 IRF2BPL	1.01e-04	150	186	7	M45769
Coexpression	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	TTF2 EGLN3 NDUFA9 RRM2 RUVBL2 RIF1 UBAC1 MOB1A KIF2A PARPBP PTTG2 SYNCRIP	1.13e-04	458	186	12	M8520
Coexpression	YANG_BREAST_CANCER_ESR1_UP	MAPT WFS1 FBP1 AHNAK	1.21e-04	36	186	4	M18299
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HGABA	BDP1 ACSL6 HNF1B SPEG PEG3 SMURF1 IDS SHANK3 RUFY3 ARFGEF3 FAT2 FADS3 SHANK2 IRF2BPL FRMPD3 TMEM178B HYDIN WNK3 AHNAK2 DOP1B	1.24e-04	1106	186	20	M39071
Coexpression	WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_DN	TTC28 DOCK11 RUFY3 TIAM1 N4BP2L2	1.52e-04	71	186	5	M707
Coexpression	BUSSLINGER_GASTRIC_IMMUNE_CELLS	BDP1 FLNA DOCK11 USP9X SESN3 IDS PPIA ACTR2 RIF1 SLAMF6 PPP2R5E TBC1D4 NFATC2 AHNAK SEL1L3 MACF1 N4BP2L2 AKAP13 KIF2A QKI SPEN ITM2B NUP153 CYTH4	1.54e-04	1492	186	24	M40023
Coexpression	NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP	USP9X ABHD2 MTMR1 U2AF2 NR4A3 RUVBL2 RUFY3 RYR3 DAP3 IFRD1 FAM117A PPP2R5E TBC1D4 TXNDC5 COPS8 LTN1 SEL1L3 SUGP1 MACF1 N4BP2L2 QKI	1.55e-04	1215	186	21	M41122
Coexpression	TRAVAGLINI_LUNG_ALVEOLAR_FIBROBLAST_CELL	COL6A3 FMO3 ICAM1 FBP1 DST ABCA6 MACF1	1.76e-04	164	186	7	M41676
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PRUNE2 HNF1B TTC28 DOCK11 DTNA COL27A1 CLSTN2 AOPEP SEL1L3 TMEM178B HYDIN	5.73e-10	191	187	11	1cb02007adb344f17ef73d58890f91298c7cf5a1
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	HNF1B DOCK11 SESN3 CLSTN2 TBC1D4 SHANK2 DNAH17 SEL1L3 HYDIN	6.40e-08	177	187	9	da8802a6351d3e510822f82e2fde8a4314a2216e
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PRUNE2 TTC28 DOCK11 DTNA COL27A1 CLSTN2 SEL1L3 TMEM178B HYDIN	1.12e-07	189	187	9	3b48b0d220cc24d5170713d61fa91f5bb6c21841
ToppCell	COVID-19-kidney-PCT-S1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	PRUNE2 HNF1B A1CF COL27A1 CHDH SHANK2 TMEM178B HYDIN	1.10e-06	183	187	8	6878d14026c3df6aa12e45dfad94b32fa9d9b0b7
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPTA1 ADGRV1 RYR3 ARFGEF3 GUCY2F ST18 DNAH9 HYDIN	1.15e-06	184	187	8	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	343B-Epithelial_cells-Epithelial-I_(AT1)-\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	HSPG2 DOCK11 WFS1 ICAM1 IDS FADS3 DST AHNAK	1.15e-06	184	187	8	c7073d1b2c4fdb154d87678b92a0629c02116972
ToppCell	343B-Epithelial_cells-Epithelial-I_(AT1)\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	HSPG2 DOCK11 WFS1 ICAM1 IDS FADS3 DST AHNAK	1.15e-06	184	187	8	1ed558a88215b248431c524ea16f13d9022ae98c
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPTA1 ADGRV1 RYR3 ARFGEF3 GUCY2F ST18 DNAH9 HYDIN	1.15e-06	184	187	8	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPTA1 ADGRV1 RYR3 ARFGEF3 GUCY2F ST18 DNAH9 HYDIN	1.15e-06	184	187	8	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PRUNE2 DOCK11 DTNA COL27A1 CHDH SEL1L3 TMEM178B HYDIN	1.24e-06	186	187	8	f28d72b47624b69a580b4429e2be560a26898591
ToppCell	COVID-19-kidney-tDL\|kidney / Disease (COVID-19 only), tissue and cell type	PRUNE2 MAPT DTNA COL27A1 CHDH RUFY3 SEL1L3 TMEM178B	1.30e-06	187	187	8	d35d27ca3c0e65f92f4508e1cb98a743f44fdcdf
ToppCell	COPD-Multiplet-Multiplet\|World / Disease state, Lineage and Cell class	RRM2 ARFGEF3 DNAH12 SHANK2 NFATC2 NCR1 DNAH9 HYDIN	1.35e-06	188	187	8	186fe1ea328c942910190a4240262c0d8642ea3b
ToppCell	facs-GAT-Fat-3m\|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLNA USP9X PEG3 IDS AHNAK GLUD1 MOB1A QKI	1.46e-06	190	187	8	1d92be1b41cff59e834a9d28868f554bd1f3e471
ToppCell	facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRUNE2 WFS1 USP9X ABHD2 PEG3 RUFY3 DST ST18	1.52e-06	191	187	8	f76f3f5c7902a3659d8cbe470f96ce57c8a6744d
ToppCell	facs-Aorta-Heart-3m\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MANBA USP9X PEG3 RIF1 TBC1D4 MOB1A MACF1 HYDIN	1.58e-06	192	187	8	1ccc47792edf9ee23501c8e2165d11271636b66a
ToppCell	droplet-Liver-LIVER_HEP-30m-Endothelial\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HSPG2 FLT4 TTC28 MAPT SHANK3 TJP1 CLEC14A PCDHGC3	1.64e-06	193	187	8	826b8dd801298b3e0cd76232feae5a14026b8806
ToppCell	droplet-Liver-LIVER_HEP-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HSPG2 FLT4 TTC28 MAPT SHANK3 TJP1 CLEC14A PCDHGC3	1.64e-06	193	187	8	87d3a577d37fb0cb4b6313c596310de452bc3872
ToppCell	droplet-Liver-LIVER_HEP-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HSPG2 FLT4 TTC28 MAPT SHANK3 TJP1 CLEC14A PCDHGC3	1.64e-06	193	187	8	d485634c564b268e344b6a2863c26f6adaec9e38
ToppCell	COPD-Multiplet\|COPD / Disease state, Lineage and Cell class	ERICH3 RRM2 ARFGEF3 DNAH12 SHANK2 MACF1 DNAH9 HYDIN	1.84e-06	196	187	8	6d02d494196e3f857d53eea46d9419690d43beca
ToppCell	COPD-Multiplet-Multiplet\|COPD / Disease state, Lineage and Cell class	ERICH3 RRM2 ARFGEF3 DNAH12 SHANK2 MACF1 DNAH9 HYDIN	1.84e-06	196	187	8	af4cdc61830685a888a1209826c23bcf54a43084
ToppCell	mLN-B_cell-B_cell_cycling\|B_cell / Region, Cell class and subclass	CDC42EP4 TTC28 CHDH ARHGAP11A RRM2 TBC1D4 SHANK2 PARPBP	1.91e-06	197	187	8	2071526fe46de8359ea118ff78581eb4454aa55a
ToppCell	normal_Lung-Epithelial_cells-AT1\|Epithelial_cells / Location, Cell class and cell subclass	HSPG2 FLNA WFS1 FADS3 DST AHNAK QKI ITM2B	1.91e-06	197	187	8	7d19b93d6853828e2a036e37c4887edb1de4503c
ToppCell	5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ARHGAP32 ERICH3 FMO3 DNAH12 CLMN AHNAK DNAH9 HYDIN	1.99e-06	198	187	8	d0ecace1fad24ce50b0935036fabb07e6c9e372d
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	WFS1 DTNA ADGRV1 RYR3 KIAA0319 GLUD1 MROH7 MACF1	2.14e-06	200	187	8	d0812817ef99608994193787a62d39adeb2070ca
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	WFS1 DTNA ADGRV1 RYR3 KIAA0319 GLUD1 MROH7 MACF1	2.14e-06	200	187	8	cd54ddf1919c98e84b7e4aba85b374fc8b407206
ToppCell	343B-Lymphocytic-NK_cells-NK_cell_D2\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	FLT4 CHDH LPCAT2 EGR4 HPS6 GLUD1 LTN1	4.81e-06	158	187	7	74aa4f75307575ac3b2b1aa9f727753692f88742
ToppCell	Bronchial-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	PRUNE2 DTNA SPEG PEG3 NFATC4 CSPG4 ARHGEF37	5.01e-06	159	187	7	7cda111bb98f1241989e49d490bdf51a712ea589
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Crispld2_Kcne4\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	COL6A3 EGLN3 CNMD CLSTN2 TIAM1 NFATC2 ST18	5.44e-06	161	187	7	be77e99faf653480c166305df3a4e93db76f0dcb
ToppCell	COVID-19-kidney-PEC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	PRUNE2 HNF1B COL27A1 TRIM43B SHANK2 TMEM178B HYDIN	7.20e-06	168	187	7	a086c306be430adf0632ba53e98cd8014d2de330
ToppCell	Frontal_cortex-Macroglia-POLYDENDROCYTE\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	ADAMTS4 COL20A1 CILK1 FBP1 GUCY2F QKI ST18	7.48e-06	169	187	7	50cc0f5a022b95986949db63208a627cef9f4a69
ToppCell	droplet-Pancreas-Exocrine-18m\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HSPG2 FLNA EGLN3 CHDH FADS3 CLMN AHNAK	7.48e-06	169	187	7	53690d6f9712b54aa99a0408aae930d64ae478e5
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Epithelial-neuro-epithelial-I_cells_(CCK+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	A1CF ERICH3 SEC11C KIAA0319 ARFGEF3 DNAH12 ST18	8.39e-06	172	187	7	2651dece87c3e3d2d6370f5274ebae357474b825
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PRUNE2 HNF1B DOCK11 TBC1D4 DNAH17 SEL1L3 HYDIN	9.75e-06	176	187	7	327a3e81b724252e36d786de92a3ffd721ea6d7b
ToppCell	severe-Myeloid-Neutrophils_1\|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	IDS NUDT5 AVIL IRF2BPL TOPORS ITM2B PTTG2	1.01e-05	177	187	7	d1ad35ee3d2a84b1d01126d0a38464ab858c00d0
ToppCell	NS-moderate-d_0-4-Lymphoid-NKT-proliferating\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	ADAMTS4 TRAIP XRCC2 ARHGAP11A RRM2 APOBEC2 PARPBP	1.01e-05	177	187	7	174c54acfe19e2bb31418d69e228032ba724cbb6
ToppCell	facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	WFS1 USP9X ABHD2 PEG3 DST APOBEC2 ST18	1.05e-05	178	187	7	fcbbcc44271515de1969b4732b6441c012693d5f
ToppCell	wk_15-18-Mesenchymal-Chondrocyte-ASPN+_chondrocyte\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	COL27A1 CNMD PEG3 AVIL CSPG4 MROH7 AHNAK2	1.05e-05	178	187	7	a55130670aa95a87b833dd3cd2de461d779e4c06
ToppCell	COVID-19-Heart-VSMC\|Heart / Disease (COVID-19 only), tissue and cell type	PRUNE2 FLNA ADAMTS4 SPEG COL27A1 CLMN CSPG4	1.09e-05	179	187	7	a69ad6912b5c10bb9f9d800f724c792341e9bab1
ToppCell	facs-Marrow-B-cells-3m-Myeloid-CD4+_macrophage\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	WFS1 TEX2 CHDH FADS3 AHNAK PADI2 CYTH4	1.13e-05	180	187	7	bf8d13d4db1af55b8c9fe16aaccf8743e000e005
ToppCell	droplet-Liver-LIVER_HEP-30m\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HSPG2 TTC28 MAPT SHANK3 AHNAK MACF1 PCDHGC3	1.13e-05	180	187	7	dd1b10c7f5a0fbc63163844ca1882884a24a84d3
ToppCell	facs-Marrow-B-cells-3m-Myeloid-macrophage\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	WFS1 TEX2 CHDH FADS3 AHNAK PADI2 CYTH4	1.13e-05	180	187	7	82965ed1b72a1873c24dd4553d39681596057316
ToppCell	facs-Marrow-B-cells-3m-Myeloid\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	WFS1 TEX2 CHDH FADS3 AHNAK PADI2 CYTH4	1.13e-05	180	187	7	839defb40f7cfb2711e9025194de636533f51bcd
ToppCell	COVID-19-kidney-tDL\|COVID-19 / Disease (COVID-19 only), tissue and cell type	PRUNE2 A1CF MAPT COL27A1 CHDH SHANK2 TMEM178B	1.13e-05	180	187	7	864c895b5eaedefae86f5829fa344f7b686fb59f
ToppCell	droplet-Liver-LIVER_HEP\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HSPG2 TTC28 MAPT SHANK3 AHNAK MACF1 PCDHGC3	1.13e-05	180	187	7	423454e3390080ae03bb3cbb267255ebfe4df080
ToppCell	droplet-Liver-nan-3m-Endothelial-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HSPG2 ARHGAP32 FLT4 TTC28 CILK1 FADS3 CLEC14A	1.17e-05	181	187	7	fcc94f04dae98b817ec06b282d2e887804d37ae5
ToppCell	facs-Marrow-B-cells-18m-Myeloid-CD4+_macrophage\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	WFS1 TEX2 CHDH FADS3 AHNAK PADI2 CYTH4	1.17e-05	181	187	7	782716b8b1d447d2bbe09a693fa5ed7ebeac0efb
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PRUNE2 HNF1B DOCK11 CLSTN2 ADGRV1 SEL1L3 TMEM178B	1.17e-05	181	187	7	9d782ba5cf5a172cb4f447763fc50e5b13ef7dd9
ToppCell	5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PRUNE2 COL6A3 ADAMTS4 DTNA CLSTN2 SLAMF6 DST	1.17e-05	181	187	7	b116c68393d8836bac080f81a8fcbeb52e0403e7
ToppCell	facs-Marrow-B-cells-18m-Myeloid-macrophage\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	WFS1 TEX2 CHDH FADS3 AHNAK PADI2 CYTH4	1.17e-05	181	187	7	e2481291c236105774c53883e6f20da11941df9b
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PRUNE2 HNF1B DOCK11 COL27A1 SEL1L3 TMEM178B HYDIN	1.17e-05	181	187	7	6956ecd6264f7469a25e555673bce4eb97d28f7a
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PRUNE2 HNF1B DOCK11 CLSTN2 ADGRV1 SEL1L3 TMEM178B	1.21e-05	182	187	7	eb138aa1dca9373f1586600f258df06dcf56d81f
ToppCell	5'-Airway_Nasal-Immune_Myeloid-Myeloid_macrophage-lung_macrophage-Interstitial_macrophage_perivascular-Interstitial_macrophage_perivascular_L.1.2.1.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ADAMTS4 TIAM1 LPCAT2 GSDMA QKI ITM2B CYTH4	1.21e-05	182	187	7	7909089ed6325c44edd6f9b7e8b1d542398222ea
ToppCell	5'-Airway_Nasal-Immune_Myeloid-Myeloid_macrophage-lung_macrophage\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ADAMTS4 TIAM1 LPCAT2 GSDMA QKI ITM2B CYTH4	1.21e-05	182	187	7	4a85429d365c4b2d73fc921f261b4b7635ac40bd
ToppCell	5'-Airway_Nasal-Immune_Myeloid-Myeloid_macrophage-lung_macrophage-Interstitial_macrophage_perivascular\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ADAMTS4 TIAM1 LPCAT2 GSDMA QKI ITM2B CYTH4	1.21e-05	182	187	7	53213af34af3337f5edc734d3b7b79e4349eac0d
ToppCell	wk_20-22-Mesenchymal-Chondrocyte-Resting_chondrocyte\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	PCDHGA3 COL27A1 CNMD PEG3 AOPEP CSPG4 ENTPD5	1.21e-05	182	187	7	03a5a02acd48f0eb210485348bfe0cd21f486215
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PRUNE2 HNF1B DOCK11 TBC1D4 DNAH17 SEL1L3 HYDIN	1.26e-05	183	187	7	92fbd83a9d13ee91065cbd479fb298f1fd564568
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive\|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	DTNA DST NFATC2 MACF1 N4BP2L2 AKAP13 TMEM178B	1.30e-05	184	187	7	d2bf0135eb56bb410997dccea39c5ede88a0617f
ToppCell	COVID-19-kidney-PCT-S1\|kidney / Disease (COVID-19 only), tissue and cell type	PRUNE2 DOCK11 COL27A1 CHDH SEL1L3 TMEM178B HYDIN	1.30e-05	184	187	7	51ed1ebfdef45149541917c66cbacad87072e51f
ToppCell	pdx-Tumor_cells-T0\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	A1CF COL27A1 SHANK2 NFATC2 CLMN GLUD1 ST18	1.35e-05	185	187	7	1d874608aa2062024323512f68889219471b2f00
ToppCell	PCW_10-12-Epithelial-Epithelial_neuroendo-epi_neuroendocrine1[NE1]_(11)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	PRUNE2 A1CF ERICH3 HTR2C SEC11C ARFGEF3 ST18	1.44e-05	187	187	7	98477ba04a42a8da80a72f41a182429f46283595
ToppCell	human_hepatoblastoma-Tumor_cells-T2\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	A1CF COL27A1 CHDH SHANK2 NFATC2 CLMN GLUD1	1.44e-05	187	187	7	f3e37c18ac6471c7992609bbddfa4975571c815c
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PRUNE2 HNF1B DOCK11 ADGRV1 DNAH17 SEL1L3 TMEM178B	1.44e-05	187	187	7	c41a2c81dd2ceef303f39f699032aa7d6ea67cf0
ToppCell	COVID-19-Fibroblasts-Airway_smooth_muscle\|COVID-19 / group, cell type (main and fine annotations)	PRUNE2 COL6A3 TTC28 DTNA SPEG DST AOPEP	1.44e-05	187	187	7	464a0c3b92b778911b5f9cd73642e09e3472063a
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ARHGAP32 HNF1B CECR2 CLSTN2 ADGRV1 ARFGEF3 SHANK2	1.50e-05	188	187	7	4bdf8d49af0e9da349b16e3f012e1b0eec04cc4f
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ADAMTS4 COL20A1 CLMN CSPG4 QKI PADI2 ST18	1.50e-05	188	187	7	d9692b6048d9b85524a07a1807bdd4757731c151
ToppCell	droplet-Liver-LIVER_NPC-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HSPG2 FLT4 PCDHGA3 SHANK3 TIAM1 TJP1 CLEC14A	1.50e-05	188	187	7	0aa8747c2931b0c91f6d78bb2db8fd8ede6dd559
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PRUNE2 A1CF MAPT COL27A1 CHDH CLSTN2 TMEM178B	1.55e-05	189	187	7	204ab61ae606b2d9be0cb6bf6a83a011740693a8
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PRUNE2 A1CF MAPT COL27A1 CHDH CLSTN2 TMEM178B	1.55e-05	189	187	7	13fd07cc408a9486f61a7b2c3a132c52d14b438d
ToppCell	COVID-19-kidney-PCT-S2\|kidney / Disease (COVID-19 only), tissue and cell type	PRUNE2 DTNA COL27A1 CHDH CLSTN2 SEL1L3 TMEM178B	1.55e-05	189	187	7	0be5c669b6b308bd98ddb70c84877c62a6244bbd
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PRUNE2 HNF1B DTNA ADGRV1 DNAH17 SEL1L3 TMEM178B	1.60e-05	190	187	7	1cf023e3c6924d6a06f353d4b62444b6f2fee8a7
ToppCell	PCW_10-12-Epithelial-Epithelial_neuroendo\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	PRUNE2 ERICH3 HTR2C SEC11C ADGRV1 ARFGEF3 ST18	1.60e-05	190	187	7	2375e604eacd38f61f3e661ba2f76d286fcceca7
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PRUNE2 TTC28 MAPT DTNA CLSTN2 SEL1L3 TMEM178B	1.60e-05	190	187	7	989d4eefd22d66ecb857836f8fdbcf41e3047f84
ToppCell	PCW_07-8.5-Epithelial-Epithelial_airway-epi_intermediate_(1)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	HNF1B SEC11C ADGRV1 ARFGEF3 FBP1 SHANK2 SEL1L3	1.60e-05	190	187	7	c95032bb3ee2b3d40fdf48016acb46d6f78a48a6
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Ascending_Thin_Limb_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PRUNE2 HNF1B DTNA ADGRV1 DNAH17 SEL1L3 TMEM178B	1.60e-05	190	187	7	59bbbd2c8d4b7ce46c54ca8022b1557e7e5eee2a
ToppCell	PCW_07-8.5-Epithelial-Epithelial_neuroendo-epi_neuroendocrine1[NE1]_(11)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	PRUNE2 ERICH3 HTR2C SEC11C ARFGEF3 TMEM178B ST18	1.60e-05	190	187	7	b1095b2a7467c152d16e4f19a9515aeb61fc9e3d
ToppCell	Control-Epithelial-Ciliated_cells\|Control / Condition, Lineage and Cell class	ERICH3 RYR3 ARFGEF3 DNAH12 DNAH9 HYDIN AHNAK2	1.66e-05	191	187	7	ea1d2c6838119b7019e9a2ff71d6212262b51b57
ToppCell	facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRUNE2 TTC28 WFS1 PEG3 ARFGEF3 DST AKAP13	1.66e-05	191	187	7	3387b95a3f2445c672d407922fdce3a91eabaef8
ToppCell	Control-Epithelial\|Control / Condition, Lineage and Cell class	ERICH3 RYR3 ARFGEF3 DNAH12 DNAH9 HYDIN AHNAK2	1.66e-05	191	187	7	6228302febdb3dffe37dece7062d27ac9ccc6d4b
ToppCell	Entopeduncular-Macroglia-OLIGODENDROCYTE-O1\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	COL6A3 SEC11C ADGRV1 FAT2 ABCA6	1.71e-05	76	187	5	254d18bece2676faa4bbeb8d48b1d327ab3c2215
ToppCell	Entopeduncular-Macroglia-OLIGODENDROCYTE-O1-Trf\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	COL6A3 SEC11C ADGRV1 FAT2 ABCA6	1.71e-05	76	187	5	efbbbf91bca35720d8ecddb076f2c9f4de25e44d
ToppCell	3'-Child04-06-SmallIntestine-Epithelial-Tuft-related\|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ABHD2 COL27A1 CNMD CHDH CLMN AVIL ST18	1.71e-05	192	187	7	d6ea34391c3f730684b82e912d9cf55e928b3311
ToppCell	10x3'2.3-week_14-16-Endothelial-stroma-immature_EC\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	HSPG2 FLT4 WFS1 SHANK3 TJP1 CLEC14A TMEM178B	1.71e-05	192	187	7	5af3b2b38495e925497c48f605d618bbf970965d
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive\|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	ADAMTS4 DTNA NFATC1 NFATC2 SEL1L3 MACF1 AKAP13	1.71e-05	192	187	7	8b86db2ebe0199fee0e9800566a619a24bfdeed5
ToppCell	PCW_13-14-Epithelial-Epithelial_neuroendo\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	PRUNE2 HTR2C SEC11C ADGRV1 ARFGEF3 EGR4 ST18	1.77e-05	193	187	7	8603d1a38955ad2529d04e4704467c73ea5bfbda
ToppCell	CF-Myeloid-cDC\|Myeloid / Disease state, Lineage and Cell class	INPP5F RUFY3 TBC1D4 DST NFATC2 SEL1L3 ST18	1.83e-05	194	187	7	3feb8a0ba3368673c53e9cbd4980e73d18697718
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	COL6A3 TTC28 DST TIAM1 ABCA6 MACF1 TMEM178B	1.83e-05	194	187	7	b1bb0f846d2865efdd9bc8842b16b9d069785882
ToppCell	5'-Adult-Appendix-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	COL6A3 FMO3 ADAMTS4 ICAM1 NR4A3 CLSTN2 ABCA6	1.89e-05	195	187	7	fc43cd295f2cc3f6e9442232e028944f011c82cc
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TTC28 USP9X PEG3 RIF1 DST MACF1 ST18	1.89e-05	195	187	7	7796ea9247f4c63762f0de8490fed08b9717fa23
ToppCell	facs-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRUNE2 TTC28 WFS1 PEG3 IDS ARFGEF3 DST	1.89e-05	195	187	7	bd8e24dd598990204998d1dd853ba7a53dc0107e
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	COL6A3 TTC28 DST TIAM1 ABCA6 MACF1 TMEM178B	1.89e-05	195	187	7	0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937
ToppCell	COVID-19-T_cells-Cycling_NK/T_cells\|COVID-19 / group, cell type (main and fine annotations)	TTF2 SPTA1 CKAP5 ARHGAP11A RRM2 NFATC2 PARPBP	1.89e-05	195	187	7	764ed100c28d9bc93ee5ecabc5291c8f184d78da
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TTC28 USP9X PEG3 RIF1 DST MACF1 ST18	1.89e-05	195	187	7	3e519cffa6144a62b06124642a14c9ff39b76554
ToppCell	Epithelial-Epithelial-A_(AT1)\|Epithelial / shred on cell class and cell subclass (v4)	HSPG2 ICAM1 FADS3 TJP1 AHNAK MACF1 QKI	1.96e-05	196	187	7	41b21a18125cc95bc8adde3369e4abd029cf137d
ToppCell	Epithelial_cells-AT1_cells\|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id	HSPG2 FLNA WFS1 ICAM1 FADS3 DST AHNAK	1.96e-05	196	187	7	6c99d29162848161c1f166a032320f87a5d5a631
ToppCell	10x3'2.3-week_14-16-Myeloid_macrophage-stroma\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	COL27A1 ICAM1 NR4A3 ARFGEF3 NFATC1 ITM2B AHNAK2	1.96e-05	196	187	7	bd2c2de103e28b65ea537c22f71225cb0deef1e0
ToppCell	3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-Alveolar_macrophage_proliferating_L.1.0.7.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	HSPG2 ADAMTS4 ARHGAP11A RRM2 SHANK3 FBP1 PARPBP	1.96e-05	196	187	7	eb8c9a4a5eb21d43ff7b25deae5896c236f669b9
ToppCell	10x3'2.3-week_14-16-Myeloid_macrophage\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	COL27A1 ICAM1 NR4A3 ARFGEF3 NFATC1 ITM2B AHNAK2	1.96e-05	196	187	7	072a4150ae521c6589b0f7cd60e975fb33715bf4
ToppCell	Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PRUNE2 COL6A3 ADAMTS4 SPEG COL27A1 AIRE CLSTN2	2.02e-05	197	187	7	cfb3dc4b401800e33c82cfc3baee69dbbd16ac8c
ToppCell	droplet-Trachea-nan-3m-Mesenchymal-chondrocyte\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A3 COL27A1 CNMD NFATC1 NFATC2 CSPG4 IRF2BPL	2.02e-05	197	187	7	8786125b669d5d0b15e12df0ade6b319f09f7333
ToppCell	3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary-EC_venous_pulmonary_L.2.2.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	HSPG2 ARHGAP11A RRM2 SHANK3 CLEC14A TMEM178B PARPBP	2.02e-05	197	187	7	76b61e60a757e58b465569538e632d6d9953e89a
Computational	Genes upregulated in subsets of cells of a given type within various tumors	BDP1 RIF1 DST TJP1 MACF1 SPEN	2.86e-05	50	130	6	GAVISH_3CA_MALIGNANT_METAPROGRAM_4_CHROMATIN
Drug	ws 10	FBP1 GLUD1 GLUD2 PKLR GOT2	6.68e-08	14	187	5	CID000107151
Drug	Medrysone [2668-66-8]; Down 200; 11.6uM; MCF7; HT_HG-U133A	TRAIP DVL2 CUL7 CEP164 RUFY3 CLMN MSL3 N4BP2L2 AKAP13 ZNF606 QKI	7.81e-07	198	187	11	3603_DN
Drug	AC1O3MP2	MAPT APRT GLUD1 GLUD2	1.39e-06	11	187	4	CID006332324
Drug	8-BDB-TADP	GLUD1 GLUD2 PKLR	2.17e-06	4	187	3	CID000130791
Drug	Luteolin [491-70-3]; Down 200; 14uM; MCF7; HT_HG-U133A	EGLN3 DTNA RRM2 SHANK2 NFATC1 CLMN SUGP1 N4BP2L2 QKI SYNCRIP	4.07e-06	190	187	10	3379_DN
Drug	Nitrendipine [39562-70-4]; Up 200; 11uM; HL60; HT_HG-U133A	HNF1B ABHD2 ICAM1 NR4A3 RIF1 EGR4 AHNAK DNAH17 AP1G2 PADI2	4.46e-06	192	187	10	3087_UP
Drug	LY 294002; Up 200; 10uM; HL60; HT_HG-U133A	MAPT DTNA ABHD2 TRAIP ICAM1 SMURF1 CILK1 NR4A3 SUGP1 CYTH4	5.36e-06	196	187	10	1168_UP
Drug	Cinnarizine [298-57-7]; Down 200; 10.8uM; HL60; HG-U133A	FLNA DTNA ABHD2 ICAM1 IDS WDR19 AHNAK SUGP1 ITM2B SYNCRIP	5.36e-06	196	187	10	1558_DN
Drug	Pralidoxime chloride [51-15-0]; Down 200; 23.2uM; HL60; HT_HG-U133A	A1CF CDC42EP4 TRAIP DVL2 NR4A3 IDS RUFY3 AHNAK SUGP1 AP1G2	5.36e-06	196	187	10	3066_DN
Drug	adenine N1-oxide	GLUD1 GLUD2 PKLR	5.39e-06	5	187	3	CID000093557
Drug	choline sulfate	CHDH GLUD1 GLUD2	5.39e-06	5	187	3	CID000000485
Drug	(S)-(-)-Atenolol [93379-54-5]; Up 200; 15uM; HL60; HT_HG-U133A	FLT4 CNMD ICAM1 SMURF1 NR4A3 CLSTN2 EGR4 APOBEC2 DNAH17 SUGP1	5.86e-06	198	187	10	3067_UP
Drug	Cefmetazole sodium salt [56796-39-5]; Down 200; 8.2uM; MCF7; HT_HG-U133A	HSPG2 TTC28 PDE6B TRAIP DVL2 PSMD11 CEP164 RUFY3 SUGP1 ZNF606	6.13e-06	199	187	10	6086_DN
Drug	quinocetone	ACSL6 HSPG2 CYP11A1 PEG3 ADGRV1 PPIA RUVBL2 RYR3 DNAH12 AVIL TPI1	6.91e-06	248	187	11	ctd:C502851
Drug	2-BDB-TAMP	GLUD1 GLUD2 PKLR	1.07e-05	6	187	3	CID000127220
Drug	2 pc	IL31RA CSPG4 GLUD1 GLUD2	1.23e-05	18	187	4	CID000440046
Drug	Thimerosal	BDP1 EGLN3 HTR2C DOCK11 BBIP1 ADGRV1 NDUFA9 PPIA MAP3K6 ACTR2 RYR3 ARFGEF3 CCNT1 NBAS DST LTN1 MOB1A N4BP2L2 FRMPD3 PARPBP SPEN AHNAK2 SYNCRIP SPATC1L TPI1	1.75e-05	1199	187	25	ctd:D013849
Drug	carbophenothion	FMO3 GLUD1 GLUD2	1.86e-05	7	187	3	CID000013081
Drug	37474A	GLUD1 GLUD2 PKLR	1.86e-05	7	187	3	CID004330138
Drug	tetrachlorosalicylanilide	FLT4 IL31RA PKLR	1.86e-05	7	187	3	CID000124579
Drug	2-oxoglutaconic acid	GLUD1 GLUD2 GOT2	1.86e-05	7	187	3	CID006443759
Drug	retinoic acid; Down 200; 1uM; MCF7; HT_HG-U133A	FLT4 WFS1 DTNA TRAIP MAP3K6 FADS3 SHANK2 AHNAK QKI	2.76e-05	189	187	9	5208_DN
Drug	Bepridil hydrochloride [74764-40-2]; Up 200; 10uM; MCF7; HT_HG-U133A	PRUNE2 A1CF DTNA SPEG ICAM1 NR4A3 CUL7 CEP164 SHANK2	2.87e-05	190	187	9	2629_UP
Drug	Methotrexate [59-05-2]; Up 200; 8.8uM; HL60; HG-U133A	FLNA CNMD U2AF2 RRM2 IFRD1 TBC1D4 SEL1L3 AP1G2 ITM2B	3.00e-05	191	187	9	2041_UP
Drug	5155877; Up 200; 10uM; PC3; HT_HG-U133A	A1CF MAPT SMURF1 IDS RUFY3 CCNT1 SUGP1 AKAP13 QKI	3.12e-05	192	187	9	6544_UP
Drug	Methoxy-6-harmalan [3589-73-9]; Down 200; 18.6uM; MCF7; HT_HG-U133A	EXO5 TTC28 MAPT ABHD2 ICAM1 SMURF1 PSMD11 CUL7 RUFY3	3.52e-05	195	187	9	5455_DN
Drug	Amidopyrine [58-15-1]; Down 200; 17.2uM; PC3; HT_HG-U133A	HNF1B MAPT DTNA SPEG SMURF1 CEP164 RUFY3 CCNT1 RWDD2A	3.52e-05	195	187	9	4481_DN
Drug	2-propylpentanoic acid; Down 200; 1000uM; PC3; HT_HG-U133A	MAPT ABHD2 PEG3 DVL2 IDS RUFY3 TIAM1 SUGP1 PADI2	3.52e-05	195	187	9	4433_DN
Drug	Pipenzolate bromide [125-51-9]; Down 200; 9.2uM; HL60; HT_HG-U133A	FLT4 CDC42EP4 DTNA DVL2 CILK1 IDS RUFY3 ENTPD5 CYTH4	3.52e-05	195	187	9	2719_DN
Drug	Ribostamycin sulfate salt [53797-35-6]; Up 200; 7.2uM; HL60; HT_HG-U133A	PRUNE2 MAPT ICAM1 AIRE FADS3 FBP1 EGR4 CLMN DNAH17	3.52e-05	195	187	9	2705_UP
Drug	Prostaglandin E1; Down 200; 10uM; PC3; HT_HG-U133A	DTNA RUFY3 CCNT1 TBC1D4 SHANK2 PTPRH COPS8 SUGP1 AKAP13	3.67e-05	196	187	9	6571_DN
Drug	Azathymine, 6 [932-53-6]; Down 200; 31.4uM; MCF7; HT_HG-U133A	DTNA TRAIP CILK1 U2AF2 IDS TBC1D4 TIAM1 MTOR AKAP13	3.67e-05	196	187	9	2827_DN
Drug	Lidocaone hydrochloride [73-78-9]; Up 200; 14.8uM; HL60; HG-U133A	HNF1B CDC42EP4 MANBA CNMD ICAM1 BBIP1 IDS CCNT1 AP1G2	3.67e-05	196	187	9	1999_UP
Drug	Austricine [10180-88-8]; Down 200; 14.2uM; MCF7; HT_HG-U133A	CDC42EP4 MAPT DTNA TRAIP IDS RUFY3 AKAP13 QKI DOP1B	3.82e-05	197	187	9	2812_DN
Drug	Hecogenin [467-55-0]; Down 200; 9.2uM; HL60; HT_HG-U133A	FLT4 CDC42EP4 PDE6B DTNA ICAM1 CILK1 RUFY3 SUGP1 RWDD2A	3.82e-05	197	187	9	2716_DN
Drug	Bretylium tosylate [61-75-6]; Down 200; 9.6uM; MCF7; HT_HG-U133A	TTC28 MAPT SPEG ICAM1 CEP164 CCNT1 DNAH17 SUGP1 AHNAK2	3.82e-05	197	187	9	3394_DN
Drug	Tiratricol, 3,3',5-triiodothyroacetic acid [51-24-1]; Down 200; 6.4uM; MCF7; HT_HG-U133A	ABHD2 RUFY3 CCNT1 TBC1D4 COPS8 MTOR MSL3 SPEN PADI2	3.82e-05	197	187	9	7011_DN
Drug	Methylprednisolone, 6-alpha [83-43-2]; Down 200; 10.6uM; MCF7; HT_HG-U133A	DTNA TRAIP ICAM1 CILK1 CLSTN2 CUL7 IDS RUFY3 SUGP1	3.82e-05	197	187	9	6785_DN
Drug	Parbendazole [14255-87-9]; Up 200; 16.2uM; MCF7; HT_HG-U133A	PRUNE2 COL6A3 DTNA RUFY3 NFATC1 ABCA6 APOBEC2 AHNAK SUGP1	3.82e-05	197	187	9	3881_UP
Drug	Ipratropium bromide [22254-24-6]; Up 200; 9.8uM; PC3; HT_HG-U133A	A1CF MAPT ICAM1 DVL2 SMURF1 RIF1 NFATC1 SUGP1 AKAP13	3.82e-05	197	187	9	5823_UP
Drug	Lymecycline [992-21-2]; Down 200; 6.6uM; MCF7; HT_HG-U133A	DVL2 SMURF1 U2AF2 XRCC2 MSL3 SUGP1 AKAP13 ZNF606 PARPBP	3.82e-05	197	187	9	3514_DN
Drug	Sulfadimethoxine [122-11-2]; Down 200; 12.8uM; MCF7; HT_HG-U133A	FLT4 EXO5 TTC28 SMURF1 CEP164 RUFY3 TIAM1 AKAP13 QKI	3.97e-05	198	187	9	3441_DN
Drug	Ornidazole [16773-42-5]; Down 200; 18.2uM; MCF7; HT_HG-U133A	A1CF TTC28 ICAM1 DVL2 XRCC2 MAP3K6 RUFY3 SUGP1 QKI	3.97e-05	198	187	9	2272_DN
Drug	(-)-Quinpirole hydrochloride [85760-74-3]; Up 200; 15.6uM; HL60; HT_HG-U133A	ABHD2 NR4A3 RIF1 FADS3 AVIL DNAH17 SEL1L3 AKAP13	4.00e-05	153	187	8	2977_UP
Drug	Hydroquinine hydrobromide hydrate [304695-81-6]; Down 200; 9.4uM; PC3; HT_HG-U133A	MANBA MAPT ICAM1 CEP164 PTPRH TIAM1 MTOR ENTPD5 SUGP1	4.13e-05	199	187	9	5789_DN
Drug	Pentoxifylline [6493-05-6]; Up 200; 14.4uM; PC3; HT_HG-U133A	HNF1B ICAM1 DVL2 CUL7 TBC1D4 TIAM1 N4BP2L2 RWDD2A QKI	4.29e-05	200	187	9	2127_UP
Drug	Thapsigargin	COL6A3 FLT4 ADAMTS4 WFS1 DTNA USP9X PEG3 CKAP5 SEC11C NDUFA9 RRM2 WDR19 FADS3 FBP1 PTPRH NFATC1 NFATC2 TJP1 AHNAK ENTPD5 LTN1 MACF1 N4BP2L2 GOT2 SYNCRIP TPI1	4.70e-05	1353	187	26	ctd:D019284
Drug	2,4,5,2',5'-pentachlorobiphenyl	PRUNE2 ACSL6 TTF2 FLNA COL6A3 HTR2C TTC28 DOCK11 TEX2 DTNA CYP11A1 CECR2 SPTA1 TRAIP ARHGAP11A RRM2 CEP164 FAT2 TBC1D4 SHANK2 LTN1 HELZ2 MROH7 FRMPD3 ARHGEF37 ZNF606 PARPBP	5.11e-05	1441	187	27	ctd:C009828
Drug	phenyltriethoxysilane	GLUD1 GLUD2	6.71e-05	2	187	2	CID000013075
Drug	G-3SH	GLUD1 GLUD2	6.71e-05	2	187	2	CID000174237
Drug	iodoacetyldiethylstilbestrol	GLUD1 GLUD2	6.71e-05	2	187	2	CID006455327
Drug	methylmercuric bromide	GLUD1 GLUD2	6.71e-05	2	187	2	CID000068175
Drug	5-methylisophthalate	GLUD1 GLUD2	6.71e-05	2	187	2	CID000068137
Drug	methyl dimethyldithiocarbamate	CLSTN2 TPI1	6.71e-05	2	187	2	CID000019526
Drug	x 1 s	GLUD1 GLUD2	6.71e-05	2	187	2	CID000409694
Drug	CuCl2	CUL7 DST PPP4C COPS8 MTOR	8.08e-05	54	187	5	CID000024014
Drug	methionine sulfoximine	FBP1 MTOR GLUD1 GLUD2 MSL3 NUP153	8.24e-05	87	187	6	CID000016118
Drug	PMSA	FLNA FLT4 DST	8.57e-05	11	187	3	CID000125605
Drug	kievitone	SUMF2 GLUD1 GLUD2	8.57e-05	11	187	3	CID000119269
Drug	thiourea	SUMF2 FMO3 CLSTN2 FADS3 SHANK2 PKLR PADI2	9.23e-05	128	187	7	CID002723790
Drug	2,4,4'-trichlorobiphenyl	PRUNE2 ACSL6 TTF2 FLNA COL6A3 HTR2C TTC28 DOCK11 TEX2 DTNA CECR2 SPTA1 TRAIP ARHGAP11A RRM2 CEP164 FAT2 TBC1D4 SHANK2 LTN1 HELZ2 MROH7 FRMPD3 ARHGEF37 ZNF606 PARPBP	9.37e-05	1411	187	26	ctd:C081766
Drug	Methylthioacetylaminoethanol	GLUD1 GLUD2 GOT2	1.14e-04	12	187	3	CID000155653
Drug	abrine	FLNA HTR2C COL27A1 ICAM1 CKAP5 AIRE ADGRV1 MAP3K6 SHANK2 AHNAK	1.30e-04	285	187	10	ctd:C496492
Drug	tungsten	ARHGAP32 WFS1 PPP4C GLUD1 GLUD2 PADI2	1.34e-04	95	187	6	CID000023964
Drug	Pandurol	GLUD1 GLUD2 GOT2	1.47e-04	13	187	3	CID000019618
Drug	Dilazep dihydrochloride [20153-98-4]; Down 200; 6uM; MCF7; HT_HG-U133A	TTC28 ABHD2 RUFY3 AOPEP MSL3 N4BP2L2 QKI SYNCRIP	1.51e-04	185	187	8	4688_DN
Drug	Monensin sodium salt [22373-78-0]; Down 200; 5.8uM; PC3; HT_HG-U133A	MANBA MAPT SPEG U2AF2 CCNT1 SHANK2 SUGP1 QKI	1.63e-04	187	187	8	7402_DN
Drug	Pempidine tartrate [546-48-5]; Down 200; 13uM; PC3; HT_HG-U133A	ICAM1 XRCC2 RUFY3 PTPRH ENTPD5 MOB1A AKAP13 SPEN	1.81e-04	190	187	8	4307_DN
Drug	isovalerate	SUMF2 CILK1 IDS APRT RYR3 DAP3 LPCAT2	1.84e-04	143	187	7	CID000010430
Drug	b-3p	MANBA IDS GLUD1 GLUD2	1.89e-04	35	187	4	CID000125132
Drug	Carbarsone [121-59-5]; Down 200; 15.4uM; MCF7; HT_HG-U133A	ICAM1 CLSTN2 XRCC2 MAP3K6 FADS3 AKAP13 ZNF606 QKI	1.95e-04	192	187	8	4110_DN
Drug	lenthionine	GLUD1 GLUD2	2.00e-04	3	187	2	CID000067521
Drug	NSC92228	NFATC1 NFATC4	2.00e-04	3	187	2	CID000017897
Drug	mildiomycin	GLUD1 GLUD2	2.00e-04	3	187	2	CID000125665
Drug	methoxyethylmercury	GLUD1 GLUD2	2.00e-04	3	187	2	CID000115155
Drug	4-methylumbelliferyl laurate	GLUD1 GLUD2	2.00e-04	3	187	2	CID000600674
Drug	2,6-dimethylpiperazine	CLSTN2 PPP4C	2.00e-04	3	187	2	CID000066056
Drug	methylmercuric iodide	GLUD1 GLUD2	2.00e-04	3	187	2	CID000067347
Drug	Wang resin	SPTA1 DST	2.00e-04	3	187	2	CID000070043
Drug	Dicumarol [66-76-2]; Down 200; 11.8uM; HL60; HT_HG-U133A	FLNA DTNA U2AF2 IFT46 IDS MSL3 SUGP1 QKI	2.02e-04	193	187	8	2561_DN
Drug	PHA-00851261E [724719-49-7]; Down 200; 10uM; PC3; HT_HG-U133A	HNF1B A1CF DTNA DVL2 CEP164 AHNAK SUGP1 AKAP13	2.02e-04	193	187	8	3773_DN
Drug	Nefopam hydrochloride [23327-57-3]; Down 200; 13.8uM; MCF7; HT_HG-U133A	HSPG2 PDE6B TRAIP DVL2 CLSTN2 PSMD11 RUFY3 SUGP1	2.02e-04	193	187	8	3627_DN
Drug	Fludrocortisone acetate [514-36-3]; Down 200; 9.4uM; MCF7; HT_HG-U133A	ARHGAP32 DTNA MTMR1 U2AF2 PSMD11 MOB1A SUGP1 ITM2B	2.02e-04	193	187	8	3866_DN
Drug	Albendazole [54965-21-8]; Up 200; 15uM; HL60; HG-U133A	HNF1B TTC28 NR4A3 IDS CCNT1 FBP1 MOB1A SUGP1	2.02e-04	193	187	8	1547_UP
Drug	Naftifine hydrochloride [65473-14-5]; Up 200; 12.4uM; MCF7; HT_HG-U133A	PDE6B DTNA ICAM1 SMURF1 CUL7 RUFY3 FADS3 SUGP1	2.09e-04	194	187	8	7032_UP
Drug	Neomycin sulfate [1405-10-3]; Down 200; 4.2uM; MCF7; HT_HG-U133A	MANBA DTNA TRAIP DVL2 COPS8 SUGP1 TOPORS DOP1B	2.09e-04	194	187	8	7221_DN
Drug	Oxybutynin chloride [1508-65-2]; Down 200; 10.2uM; MCF7; HT_HG-U133A	ABHD2 SMURF1 FADS3 TIAM1 MTOR HPS6 SUGP1 TOPORS	2.09e-04	194	187	8	3168_DN
Drug	3-mercaptopicolinate	FBP1 GLUD1 GLUD2 PKLR	2.11e-04	36	187	4	CID000119070
Drug	Nefopam hydrochloride [23327-57-3]; Down 200; 13.8uM; HL60; HT_HG-U133A	DTNA CILK1 PSMD11 CCNT1 COPS8 SUGP1 MACF1 AKAP13	2.17e-04	195	187	8	2355_DN
Drug	Metaraminol bitartrate [33402-03-8]; Down 200; 8.6uM; MCF7; HT_HG-U133A	FLT4 TTC28 PDE6B DTNA SMURF1 XRCC2 SUGP1 AKAP13	2.17e-04	195	187	8	4692_DN
Drug	Tranexamic acid [1197-18-8]; Up 200; 25.4uM; PC3; HT_HG-U133A	MAPT ABHD2 PEG3 U2AF2 TBC1D4 SHANK2 AKAP13 RWDD2A	2.17e-04	195	187	8	2085_UP
Drug	Benperidol [2062-84-2]; Down 200; 10.4uM; HL60; HT_HG-U133A	A1CF DTNA MTMR1 CCNT1 TBC1D4 FADS3 FBP1 KIF2A	2.17e-04	195	187	8	2475_DN
Drug	Aconitine [302-27-2]; Down 200; 6.2uM; MCF7; HT_HG-U133A	HSPG2 EXO5 A1CF MANBA TRAIP U2AF2 CUL7 SHANK2	2.17e-04	195	187	8	2776_DN
Drug	Sulfamethoxypyridazine [80-35-3]; Down 200; 14.2uM; MCF7; HT_HG-U133A	MAPT DTNA SMURF1 XRCC2 IDS FADS3 HPS6 SUGP1	2.17e-04	195	187	8	3409_DN
Drug	Orlistat; Up 200; 10uM; MCF7; HT_HG-U133A	SPEG NR4A3 PTPRH APOBEC2 AHNAK MSL3 PKLR PCDHB1	2.17e-04	195	187	8	6415_UP
Drug	Mycophenolic acid [24280-93-1]; Down 200; 12.4uM; PC3; HT_HG-U133A	PDE6B MAPT SMURF1 RUFY3 SHANK2 MSL3 SUGP1 AKAP13	2.17e-04	195	187	8	4019_DN
Drug	Oxymetazoline hydrochloride [2315-02-8]; Down 200; 13.4uM; MCF7; HT_HG-U133A	A1CF TRAIP U2AF2 XRCC2 CLMN DNAH17 MSL3 SUGP1	2.17e-04	195	187	8	2278_DN
Drug	Nabumetone [42924-53-8]; Down 200; 17.6uM; MCF7; HT_HG-U133A	EXO5 TTC28 PSMD11 WDR19 HPS6 SUGP1 ZNF606 QKI	2.17e-04	195	187	8	5428_DN
Drug	Piromidic acid [19562-30-2]; Down 200; 13.8uM; MCF7; HT_HG-U133A	HSPG2 DTNA ABHD2 CUL7 SUGP1 KIF2A SPEN ITM2B	2.17e-04	195	187	8	4398_DN
Drug	Molindone hydrochloride [15622-65-8]; Down 200; 12.8uM; MCF7; HT_HG-U133A	DTNA TRAIP SMURF1 U2AF2 CUL7 WDR19 FADS3 SUGP1	2.17e-04	195	187	8	4784_DN
Disease	Conventional (Clear Cell) Renal Cell Carcinoma	HNF1B FLT4 CILK1 CUL7 APRT MTOR AHNAK AKAP13 WNK3	3.23e-07	148	179	9	C0279702
Disease	collagen alpha-3(VI) chain measurement	COL6A3 COPS8	3.66e-05	2	179	2	EFO_0802421
Disease	mean platelet volume	ARHGAP32 TTC28 DOCK11 TEX2 PCDHGA3 SPTA1 SMURF1 MTMR1 ATG14 XRCC2 PPIA SHANK3 TBC1D4 NFATC1 GLIS2 N4BP2L2 KIF2A PCDHGC3	5.26e-05	1020	179	18	EFO_0004584
Disease	Ciliopathies	ADGRV1 CEP164 WDR19 GLIS2 CC2D2A TOPORS	5.82e-05	110	179	6	C4277690
Disease	fascioliasis (biomarker_via_orthology)	GLUD1 GLUD2	1.09e-04	3	179	2	DOID:885 (biomarker_via_orthology)
Disease	Sarcomatoid Renal Cell Carcinoma	HNF1B CUL7 APRT MTOR AHNAK AKAP13	1.35e-04	128	179	6	C1266043
Disease	Chromophobe Renal Cell Carcinoma	HNF1B CUL7 APRT MTOR AHNAK AKAP13	1.35e-04	128	179	6	C1266042
Disease	Collecting Duct Carcinoma of the Kidney	HNF1B CUL7 APRT MTOR AHNAK AKAP13	1.35e-04	128	179	6	C1266044
Disease	Papillary Renal Cell Carcinoma	HNF1B CUL7 APRT MTOR AHNAK AKAP13	1.35e-04	128	179	6	C1306837
Disease	Renal Cell Carcinoma	HNF1B CUL7 APRT MTOR AHNAK AKAP13	1.35e-04	128	179	6	C0007134
Disease	snoring measurement	MAPT ADGRV1 FBP1 AOPEP MACF1	1.63e-04	84	179	5	EFO_0008341
Disease	Drugs used in diabetes use measurement	HNF1B WFS1 SEC11C PTPRH NFATC2 CLEC14A MOB1B MACF1	1.75e-04	255	179	8	EFO_0009924
Disease	dextro-looped transposition of the great arteries (implicated_via_orthology)	HSPG2 DVL2	2.18e-04	4	179	2	DOID:0060770 (implicated_via_orthology)
Disease	response to carbamazepine	COL6A3 COPS8	2.18e-04	4	179	2	EFO_0008484
Disease	hyperglycemia (biomarker_via_orthology)	CYP11A1 ICAM1 PKLR	2.69e-04	21	179	3	DOID:4195 (biomarker_via_orthology)
Disease	Mouth Neoplasms	ICAM1 PPIA TIAM1 TPI1	3.27e-04	54	179	4	C0026640
Disease	Malignant neoplasm of mouth	ICAM1 PPIA TIAM1 TPI1	3.27e-04	54	179	4	C0153381
Disease	Schizophrenia	ACSL6 ARHGAP32 HTR2C ICAM1 PPIA SHANK3 ACTR2 FBP1 TXNDC5 EGR4 MTOR KIF2A QKI WNK3 TPI1	3.38e-04	883	179	15	C0036341
Disease	childhood absence epilepsy (biomarker_via_orthology)	GLUD1 GLUD2	5.40e-04	6	179	2	DOID:1825 (biomarker_via_orthology)
Disease	phosphate measurement	RYR3 MOB1A	7.53e-04	7	179	2	EFO_0010968
Disease	Nephronophthisis, familial juvenile	WDR19 GLIS2	7.53e-04	7	179	2	C1855681
Disease	Hyperammonemia	GLUD1 GOT2	7.53e-04	7	179	2	C0220994
Disease	level of Phosphatidylcholine (18:2_20:4) in blood serum	ABHD2 SUGP1	7.53e-04	7	179	2	OBA_2045109
Disease	Epileptic encephalopathy	FLNA RYR3 MTOR	7.90e-04	30	179	3	C0543888
Disease	Chromosomal Instability	CKAP5 PPP2R5E	1.00e-03	8	179	2	C1257806
Disease	Kartagener Syndrome	DNAAF5 DNAH9 HYDIN	1.25e-03	35	179	3	C0022521
Disease	Ciliary Dyskinesia, Primary, 1, With Or Without Situs Inversus	DNAAF5 DNAH9 HYDIN	1.25e-03	35	179	3	C4551906
Disease	Polynesian Bronchiectasis	DNAAF5 DNAH9 HYDIN	1.25e-03	35	179	3	C4317124
Disease	Disproportionate short stature	HSPG2 FLNA CILK1 CUL7	1.26e-03	77	179	4	C0878659
Disease	malaria (implicated_via_orthology)	ICAM1 PKLR	1.28e-03	9	179	2	DOID:12365 (implicated_via_orthology)
Disease	level of Phosphatidylcholine (16:0_20:5) in blood serum	FADS3 AHNAK	1.28e-03	9	179	2	OBA_2045077
Disease	level of Phosphatidylcholine (18:0_20:5) in blood serum	FADS3 AHNAK	1.28e-03	9	179	2	OBA_2045095
Disease	uric acid measurement	FLT4 A1CF ADGRV1 KIAA0319 NFATC1 ABCA6 NFATC2 GLUD1 SUGP1 AKAP13 FOXK1	1.31e-03	610	179	11	EFO_0004761
Disease	alkaline phosphatase measurement	HSPG2 MANBA MAPT KIAA0319 FADS3 NFATC1 ABCA6 NFATC4 AHNAK GLIS2 SUGP1 GSDMA MACF1 N4BP2L2 AKAP13	1.39e-03	1015	179	15	EFO_0004533
Disease	S-7-hydroxywarfarin to S-warfarin ratio measurement	FMO3 RRM2 TIAM1 NFATC2	1.51e-03	81	179	4	EFO_0803334
Disease	response to anticonvulsant	COL6A3 CLSTN2 COPS8 IRF2BPL	1.81e-03	85	179	4	GO_0036277
Disease	late onset Parkinson's disease (is_implicated_in)	MAPT GLUD2	1.94e-03	11	179	2	DOID:0060892 (is_implicated_in)
Disease	Enzymopathy	PKLR TPI1	1.94e-03	11	179	2	C0520572
Disease	Renal dysplasia and retinal aplasia (disorder)	CEP164 WDR19	2.32e-03	12	179	2	C0403553
Disease	PARKINSON DISEASE, LATE-ONSET	MAPT GLUD2	2.32e-03	12	179	2	C3160718
Disease	intercellular adhesion molecule 5 measurement	ICAM1 ABCA6	2.73e-03	13	179	2	EFO_0008164
Disease	Nephronophthisis	WDR19 GLIS2	2.73e-03	13	179	2	C0687120
Disease	Primary Ciliary Dyskinesia	DNAAF5 DNAH9 HYDIN	2.93e-03	47	179	3	C4551720
Disease	Malformations of Cortical Development	MTOR KIF2A	3.17e-03	14	179	2	C1955869
Disease	Cortical Dysplasia	MTOR KIF2A	3.17e-03	14	179	2	C0431380
Disease	brain ischemia (biomarker_via_orthology)	TJP1 CSPG4 GLUD1 GLUD2	3.51e-03	102	179	4	DOID:2316 (biomarker_via_orthology)
Disease	oleoyl-arachidonoyl-glycerol (18:1/20:4) [2] measurement	FADS3 SUGP1	3.65e-03	15	179	2	EFO_0800508
Disease	hepatic encephalopathy (biomarker_via_orthology)	GLUD1 GLUD2	3.65e-03	15	179	2	DOID:13413 (biomarker_via_orthology)
Disease	disease recurrence, colon carcinoma	ANAPC2 MACF1 FOXK1	3.69e-03	51	179	3	EFO_0004952, EFO_1001950
Disease	Spondyloepiphyseal Dysplasia	HSPG2 FLNA	4.15e-03	16	179	2	C0038015
Disease	Spondyloepiphyseal Dysplasia Tarda, X-Linked	HSPG2 FLNA	4.15e-03	16	179	2	C3541456
Disease	Schwartz-Jampel Syndrome, Type 1	HSPG2 FLNA	4.15e-03	16	179	2	C4551479
Disease	Schwartz-Jampel Syndrome	HSPG2 FLNA	4.15e-03	16	179	2	C0036391
Disease	Melnick-Needles Syndrome	HSPG2 FLNA	4.15e-03	16	179	2	C0025237
Disease	response to radiation, Urinary retention	COL6A3 COPS8	4.69e-03	17	179	2	GO_0009314, HP_0000016
Disease	Van Buchem disease	HSPG2 FLNA	4.69e-03	17	179	2	C0432272
Disease	Feeding difficulties	MSL3 GOT2	5.25e-03	18	179	2	C0232466
Disease	response to carboplatin	XRCC2 NBAS AKAP13	5.30e-03	58	179	3	GO_0097328
Disease	Polydactyly	USP9X CILK1 CEP164 CC2D2A	5.70e-03	117	179	4	C0152427
Disease	osteochondrodysplasia (is_implicated_in)	HSPG2 FLNA	5.85e-03	19	179	2	DOID:2256 (is_implicated_in)
Disease	Osteochondrodysplasias	HSPG2 FLNA	5.85e-03	19	179	2	C0029422
Disease	sensorineural hearing loss (implicated_via_orthology)	DNAH17 DNAH9	5.85e-03	19	179	2	DOID:10003 (implicated_via_orthology)
Disease	Dyschondroplasias	HSPG2 FLNA	5.85e-03	19	179	2	C0013366
Disease	cancer (implicated_via_orthology)	FLT4 PPP2R5E DST MTOR MACF1 TPI1	6.04e-03	268	179	6	DOID:162 (implicated_via_orthology)

Protein segments in the cluster

Peptide	Gene	Start	Entry
FLEKDPSLTEPVIRG	PPP2R5E	291	Q16537
LAEEFTEKREIPPGI	ERICH3	821	Q5RHP9
PGLLGEDSLKETVVP	ERICH3	1141	Q5RHP9
EETDDGPLLVPRVKV	BDP1	236	A6H8Y1
SFPRGKTPEVIDAIE	BDP1	1071	A6H8Y1
RDPDTPILIIKQGFE	AVIL	686	O75366
GAVPPKEEELRAAVE	ANAPC2	46	Q9UJX6
LSVPEAARTEAGKPE	CSPG4	2176	Q6UVK1
LDGSPIEVTLAKPVD	A1CF	291	Q9NQ94
FPIEEVKTGVRDPAD	ATG14	206	Q6ZNE5
VPEPAFRKLVEDALG	ARHGEF37	451	A1IGU5
ETPELPAVFDGVKLA	ABHD2	6	P08910
KVRVFEEATSPGPDL	FAM117A	346	Q9C073
FPPGEKSGEEKVILI	GSDMA	231	Q96QA5
LDKEGVFPLQPELLS	GSDMA	376	Q96QA5
EPVAPEFQGKEAIRI	ABCA6	466	Q8N139
SVPIPVIGLRDEEKV	HTR2C	186	P28335
FAGREEPEKIILPVQ	AKAP13	1326	Q12802
TGVLEFKPGEREIVI	ADGRV1	826	Q8WXG9
PIPDLKVFEREGVQL	AP1G2	666	O75843
VEVPDVSLEGPEGKL	AHNAK	2086	Q09666
VEVPDVSLEGPEGKL	AHNAK	2281	Q09666
IDVPDVNIEGPDAKL	AHNAK	4226	Q09666
VAAVPGLEKFTRSPE	AOPEP	161	Q8N6M6
IEGSENPERPFLEKA	CCNT1	441	O60563
FEFTTDKEPRGIIPL	CYTH4	291	Q9UIA0
ELTRKIGFDPEPQEK	C7orf31	306	Q8N865
VALDKDAPVPFAGEI	CLSTN2	66	Q9H4D0
FPKLTIIGEEDLPSE	BPNT1	66	O95861
ELEEGKPNPLREASF	CECR2	91	Q9BXF3
IPVPAERITLGDFKS	DVL2	31	O14641
RIFPEGKSFIADVEP	EGLN3	166	Q9H6Z9
IIKVGGERFEAPEAL	ACTR2	251	P61160
KELIELPPFEIVTGE	APOBEC2	31	Q9Y235
GRLQPILDSFPKDVD	AIRE	91	O43918
TPGVVFRDISPVLKD	APRT	21	P07741
EDPAERVLLLEAGPK	CHDH	61	Q8NE62
FIEDPTPAGLKSILE	MROH7	551	Q68CQ1
EEAPLFPGESIKAIV	MTMR1	96	Q13613
GLTDDPVLEKILFGV	OR5M10	16	Q6IEU7
LRLDVEFKPLAPDGV	HSPG2	3951	P98160
EKRSAELPDAVGPIV	QKI	66	Q96PU8
DKLDEILGEIPNPSI	PARPBP	261	Q9NWS1
LREDLPFVIKPTFGN	PCDHB1	386	Q9Y5F3
DQLIPFIDAVLKDPG	LTN1	436	O94822
ELPGFLAPEKAAVLD	EXO5	101	Q9H790
DDVNEIIRKEFSGPP	NFATC2	906	Q13469
PILEGEVFDSVKPGL	ENTPD5	76	O75356
GVLRKEPVFNDELPA	FMO3	276	P31513
FPSEPVKLLVTGDIE	NCR1	201	O76036
KSGEEALIIPPDAVA	ITM2B	21	Q9Y287
AFADDPDIPKTLGVI	NUDT14	191	O95848
PEGTRPEAKEQLLFS	IL31RA	676	Q8NI17
IRDLEDPGIDPSVVK	DST	6181	Q03001
GDEKSPLVDIPVLQF	DOP1B	1751	Q9Y3R5
FPKGRELQIPDEEVL	FRMD8P1	131	Q9BZ68
VGKIPRDLFEDELVP	SYNCRIP	166	O60506
LEGENIEIVFAKPPD	SYNCRIP	396	O60506
LGVLGPEVEKEAVSP	MAP3K6	1116	O95382
DLLPEAVRFFKEGVP	IRF2BPL	476	Q9H1B7
PEDLPEGSEIGIVKA	FAT2	2701	Q9NYQ8
KPGDGEFVEVISLPK	NUDT5	161	Q9UKK9
GEILKEELPGPTTFD	PDE6B	486	P35913
EPLTGVFKDPRVLDL	CUL7	151	Q14999
LPGVDSVLKGLPTEE	MSL3	106	Q8N5Y2
VALKVEPVGEDLGSP	NFATC1	346	O95644
ITSDLFPGIKLPEAD	DNAH12	1476	Q6ZR08
LIILGKDDENPVPDS	DNAH12	1801	Q6ZR08
ARGDLGIEIPAEKVF	PKLR	336	P30613
LDDETLFPSKIGVPF	MOB1B	126	Q7L9L4
APEARFPVIGTKIED	EGR4	331	Q05215
PEKVEGRFSAAPLVD	GLIS2	66	Q9BZE0
KLEISEAVAPGTRFP	PCDHGC3	141	Q9UN70
PVVLDSPRDGNLKDF	PADI2	366	Q9Y2J8
PLDQVAAEEVELPGK	ARHGAP32	976	A7KAX9
PEAIIVKPSDIFGRE	NDUFA9	196	Q16795
LLEVAVGPLDISPKD	NBAS	2021	A2RRP1
DLTKEPDVIIGEGPT	PEG3	26	Q9GZU2
EGESLLLSVPPGEEK	MACF1	4861	Q9UPN3
DVPLTIKDPAVGFLE	GBA	506	P04062
LGVPDLDVSGLFKEI	LPCAT2	461	Q7L5N7
PNFPTEELEIKIGEL	PCDHGA3	131	Q9Y5H0
DLRKVPGTDPAFEVF	NPC1L1	1106	Q9UHC9
PVILGSPDDVLEFLK	FBP1	316	P09467
KELTVDPTAAGDVRP	KIF2A	551	O00139
KEDEDKSGPIFIVVP	CKAP5	1151	Q14008
PREEEIVFPEKLNGS	ADAMTS4	56	O75173
EGKIPPDATLIFEIE	FKBP7	126	Q9Y680
FIPAVGDIDAFLKVP	IFT46	106	Q9NQC8
PEFEELLGKVSLPTA	IFT46	216	Q9NQC8
EKDLGVPFLDIQTPD	HYDIN	2561	Q4G0P3
PQLVPGESIREKFES	CC2D2A	1246	Q9P2K1
RLDFSGIEPDIKPFE	DOCK11	346	Q5JSL3
FFILSPGVDPLKDVE	DNAH17	3876	Q9UFH2
RAVPGTDLKIPVFDA	DMAP1	206	Q9NPF5
FLASVIAPFEIGPDK	COL20A1	201	Q9P218
GDEEVPRSPFKVKVL	FLNA	1526	P21333
NGPTTPEADKIFLER	GLUD1	406	P00367
EFLEELLKPPSQGEL	FRMPD3	1281	Q5JV73
REVLPKQGPLFVEDI	BBIP1	31	A8MTZ0
ILLEEFVKGPSPGEE	ARFGEF3	1731	Q5TH69
IPEKLEFDQVSPLFG	GUCY2F	336	P51841
PAPVSGEKDVVFLLD	COL6A3	1021	P12111
EQAFGDLTDLPVVPK	CDC42EP4	181	Q9H3Q1
GLEEKPTIAFATIPA	FOXK1	566	P85037
DVALLFKSEGPNPER	CYP11A1	106	P05108
PDRLVLDQGGEIFKT	COL27A1	1651	Q8IZC6
VELIEEPIKGSPGLS	MANBA	326	O00462
VEERDFPTETIKFGP	IFRD1	346	O00458
LREVLKLPTAVFEGP	DTNA	171	Q9Y4J8
FVGLPVEEAVKGILE	COPS8	136	Q99627
ELKREPAVGEPAEVT	ICAM1	156	P05362
FILSPGVDPLKDVES	DNAH9	3901	Q9NYC9
VDVLDVPEGTLPDKQ	IDS	186	P22304
EVLKEGSGLFPDLLV	DNAAF5	811	Q86Y56
EKVPEEVLRPGTLFT	HELZ2	2076	Q9BYK8
FTPLPEGKLKEEIEV	ZMPSTE24	226	O75844
PQGVELPSAKDLVFE	HPS6	391	Q86YV9
KDPDVTVAPVFLLGE	FADS3	231	Q9Y5Q0
NLEKIEIGPEPTLFG	INPP5F	671	Q9Y2H2
NGPTTPEADKIFLER	GLUD2	406	P49448
GARVVEPPEKDDQLV	PRAP1	46	Q96NZ9
ELEFQKGPTPAILES	MTOR	1401	P42345
EELLPSPNFGVKLET	HNF1B	31	P35680
PGFTDLPKEDQTLLI	NR4A3	456	Q92570
GDVKELAESPPLVVV	FER1L6	886	Q2WGJ9
EGKAEIIPGVLFIDE	RUVBL2	286	Q9Y230
KEGFDALDPFIPILV	DAP3	331	P51398
GPLELVEKLVPEAAE	RUFY3	131	Q7L099
PFVIIAGKRALEDPA	PARS2	431	Q7L3T8
KIELFVGGELIDPAD	USP9X	931	Q93008
SDIGRVPDFILEKIP	ARHGAP11A	236	Q6P4F7
DGPVREATVKPFAID	SUMF2	51	Q8NBJ7
IEKPLGRVGVFLDFE	TRIM43	396	Q96BQ3
GFDPEIAALIRKGEI	TMEM178B	116	H3BS89
ITGNLETFPRDPEKA	SEL1L3	846	Q68CR1
AGEIVVFKVEGRDIP	SEC11C	91	Q9BY50
KASPQEGRLIESPFE	PRUNE2	1831	Q8WUY3
ESVTLPLEFPAGEKV	SLAMF6	36	Q96DU3
PLGRVSFELFADKVP	PPIA	16	P62937
FLPDSKVVFIERGPD	NFATC4	611	Q14934
FIPPEGKDAKERILT	RIF1	1051	Q5UIP0
LDDETLFPSKIGVPF	MOB1A	126	Q9H8S9
GLTDDPVLEKILFGV	OR5M1	16	Q8NGP8
GEGVLIIFDEPPVDK	PSMD11	381	O00231
EEGELEKLFQLGPPS	PTTG2	151	Q9NZH5
FPDPNGTRLVFIDEK	WDR19	521	Q8NEZ3
EIDFEKDLLTIPPGF	SKIV2L	176	Q15477
GTREALPPKIEFVIT	RWDD2A	46	Q9UIY3
LVIDVVPPKFLGDSL	SPATC1L	306	Q9H0A9
FRLPDPFAKIVVDGS	SMURF1	31	Q9HCE7
LRGAKADTPIEEFTP	SHANK2	641	Q9UPX8
LEVPEIKTEGDKFIP	ST18	231	O60284
EGIIPESPAKLSDFL	STARD6	51	P59095
PDPILGVTEAFKRDT	GOT2	41	P00505
LPSVEVDVEAPGAKL	AHNAK2	1126	Q8IVF2
LPSVEVDVEAPGAKL	AHNAK2	1456	Q8IVF2
LPSVEVDVEAPGAKL	AHNAK2	1786	Q8IVF2
LPSVEVDVEAPGAKL	AHNAK2	3931	Q8IVF2
DSLKAFLVGIVVPDP	ACSL6	591	Q9UKU0
EFAREIGIDPIKEPE	CEP164	31	Q9UPV0
PPLEVKDLFVDIQDG	CLMN	51	Q96JQ2
PELVKIADFGLAREI	CILK1	136	Q9UPZ9
IRVDEKLGETPLVPE	CLEC14A	321	Q86T13
DKVPIALVGPDDVEF	CNMD	6	O75829
VIEKLARFVAEGGPE	SUGP1	191	Q8IWZ8
PFELPDFIKRTGIQE	SF3B2	521	Q13435
SLEGIFDDIVPDGKR	TIAM1	726	Q13009
EDEDPIGSPRLLSVK	SPEN	1271	Q96T58
TARFAVVVEGKPLPD	SPEG	1501	Q15772
LRGAKAETPIEEFTP	SHANK3	586	Q9BYB0
KAAAPGVEDEPLLRE	RRM2	61	P31350
GDLSEIIGKDEPPTL	RYR3	4301	Q15413
LTRGPSAFIPEKEVV	SESN3	36	P58005
PILEATAGDELVKLP	FLT4	341	P35916
PKARPAFSELVEILG	FLT4	1156	P35916
LVGGASLKPEFVDII	TPI1	231	P60174
AEGAIPLPVDFLSKV	MAPT	261	P10636
EDEPSGALLKPLVFR	TTLL2	76	Q9BWV7
EGFERDLVPLGDKVT	SPTA1	1226	P02549
PFRPAEILKEGSVLD	NUP153	596	P49790
PLVVFLSGEDDPEKI	TBC1D4	816	O60343
ILPKSEGGLEVEVLF	XRCC2	66	O43543
PVTIFGPIADVAREK	TJP1	646	Q07157
RSPDGPVLSKAEFVE	TTC28	46	Q96AY4
VGFVKPLAERTPELV	TOPORS	481	Q9NS56
LVKSIEIPRPVDGVE	U2AF2	411	P26368
VGDILEDKPELTPVA	TXNRD3	476	Q86VQ6
PVLAAEPEADKGTVL	TXNDC5	311	Q8NBS9
IEKPLGRVGVFLDFE	TRIM43B	396	A6NCK2
LDKGIDPDSPLFQAI	UBAC1	336	Q9BSL1
DIPLKPEVLAEDGVV	TEX2	441	Q8IWB9
DLKELFRVGGDVPET	PPP4C	61	P60510
KPELRDLVFSSPGDI	PTPRH	786	Q9HD43
ETVVAEDPAGLKVPL	TTF2	556	Q9UNY4
AKPEVISLLEQGEEP	ZNF606	106	Q8WXB4
EPDEELVGAFPIFVR	TRAIP	376	Q9BWF2
IPFEEVLERAKAGDP	WFS1	86	O76024
AIRIVDLGEEPEKPA	TRIM16L	326	Q309B1
TVLESDGERPPKLEF	WNK3	1091	Q9BYP7
VAVAGPDKELIFPVE	KIAA0319	626	Q5VV43
IEGKFLGPREEVTSE	N4BP2L2	6	Q92802